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ABSTRACT
Metallic dental implants are an important treatment for the replacement of missing teeth.
However, for esthetic and environmental issues, there is a need to develop non-metallic
dental implant materials. In this thesis, two novel glass-ceramics (GCs), miserite and
wollastonite, were synthesized for one-piece dental implant applications. Glasses were
synthesized by wet chemical methods, followed by calcination, melting and quenching.
The crystallization kinetics of these glasses were determined by differential thermal
analysis (DTA). GC specimens were produced by cold pressing of the glass powder and
sintering using schedules determined by DTA. The crystalline phases and microstructure
of the GC samples were characterized by X-ray diffraction (XRD) and scanning electron
microscopy (SEM), respectively. Miserite GC displayed an interlocking lath-like
crystalline morphology. Mechanical testing results showed Dynamic Young’s modulus
(E), 96±3 GPa, true hardness (Ho), 5.27±0.26 GPa, fracture toughness (KIC), 4.77±0.27
MPa·m0.5, and brittleness index (BI), 1.11±0.05 µm-0.5, indicating suitable mechanical
properties and machinability. Miserite GC showed excellent bioactivity, with formation
of a hydroxyapatite surface layer when soaked in simulated body fluid (SBF). Osteoblastlike cells exhibited attachment, spreading and proliferation on miserite GC surfaces,
demonstrating biocompatibility. However, preliminary studies revealed that the chemical
stability of miserite GC was not optimal, prompting us to modify the GC composition.
Accordingly, wollastonite GC was synthesized; it consisted of dense acicular interlocking
crystals and demonstrated excellent machinability. E, Ho and KIC were 90±3 GPa,
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5.15±0.47 GPa and 4.91±0.26 MPa·m0.5, respectively. Importantly, chemical durability
of wollastonite GC satisfied ISO 6872 specification for dental ceramics. Furthermore,
when evaluated according to ISO 10993-14, there was little chemical degradation. In
addition, the chemical stability tests had no significant effect on KIC (p>0.05). Bioactivity
tests revealed that wollastonite GC induced the formation of bone-like carbonated
hydroxyapatite when soaked in SBF. Moreover, wollastonite GC supported osteoblast
attachment and proliferation. Osteoblast spreading, focal adhesion formation and alkaline
phosphatase activity on this GC were comparable to those on a control zirconium-oxidebased ceramic, indicating excellent biocompatibility. In conclusion, wollastonite GC is a
promising material for non-metallic dental implant applications based on five tested
qualities: mechanical properties, chemical stability, machinability, excellent bioactivity
and biocompatibility.
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CHAPTER 1
INTRODUCTION
Overview: This Chapter provides background information on dental implants, including
an historical overview, a review of materials used for dental implants, and a description
of the most relevant mechanical parameters of dental implants. The chapter also includes
background information on glass-ceramics, including their properties and clinical
applications, pertinent aspects of bone physiology, osseointegration of dental implants,
and the bioactivity of biomaterials. It concludes with the study hypotheses and objectives
of the study and an outline of the organization of the thesis.

1.1 DENTAL IMPLANTS
Dental Implant is defined as a “prosthetic device of alloplastic material(s) implanted into
the oral tissues beneath the mucosal and/or periosteal layer, and/or within the bone to
provide retention and support for a fixed or removable prosthesis”.1 Part of most dental
implants is projected into the oral cavity and therefore subjected to wide range of physical
and biological environments, in contrast to medical implants that are placed totally inside
the body e.g. artificial hip, knee and silicone breast.2
Theoretically, implants within bone would perform the same way as the natural tooth
(Figure 1-1) through balancing between osteoblast and osteoclast activities, hence
maintaining the health of the maxilla or mandible with minimal bone resorption.3 Dental
implants must be capable of transferring occlusal forces to the adjacent bone through
osseointegration as the bone anchors to the implant surfaces.4 In general, developing an
optimal dental implant requires the collaboration among biomaterial, chemical,
mechanical, physical, and biological interdisciplinary expertise.5
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Figure 1-1: Comparison of natural tooth and implant with crown. Adapted with
permission from Dental Implants,2nd edition.6 (Appendix A)

1.1.1 Historical Overview
The replacement of missing teeth using dental implant restorations have been traced to
ancient civilizations where seashells, wood, bone, ivory, gold and stone were used.1
Throughout centuries, there were documentations of successful tooth transplantation for
restoring missing teeth; human or animal teeth were used to replace missing teeth. In the
early 19th century, cast gold tooth-root shaped implants were fixed into fresh extracted
sockets and other materials were proposed such as platinum-lead implants, iridium and
silver posts. However, complications were accompanied with different implant materials,
designs and procedures leading to the beginning of “modern era” of dental restorations in
1950s. Vitallium, an inert cast alloy, composed of cobalt, chromium and molybdenum
was proposed as a dental implant material. This alloy was used for different applications;
such as sub periosteal implants and orthopedic plates, screws, nails and joints.7
The most important milestone in dental implants was the understanding of
osseointegration phenomena by Brånemark8 in 1952. After 3 years, Brånemark and his
team used the first titanium dental implant on a human subject8. In 1978, he reported the
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breakthrough in Osseointegration Clinical Dentistry in a Toronto Conference with clinical
insertion of 2768 implants soon after that.8
The global dental implant market was valued at approximately $6.8 billion in 2011 and is
predicted to increase by an average of 9.3% per year from 2011 to 2016.9 Over one
million dental implants are inserted each year. These numbers continue to increase
progressively, with almost $550 million of implant products sold to North American
dentists in 2005.6 Success rates for mandibular implants (96-98%) and for maxillary
implants (94-96%) were reported; these appeared to depend on bone quality, surgical
techniques and primary implant retention and stability.7

1.1.2 Implant Biomaterials
Metal alloys and ceramics are the two classes of biomaterials currently used for dental
implants.

1.1.2.1 Metallic Implants
The current alloys used for dental implants belonged to two principal metallic systems:
titanium-based alloys and cobalt-based alloys1,8,10
Titanium-based alloys are considered as “materials of choice” due to their high strengthto-weight ratio, desired physical and chemical properties, high corrosion resistance,
outstanding biocompatibility, excellent fatigue feature and relatively low cost.7,11 It can
be presented either in a 99.75% pure form known as commercial pure titanium (CPTi) or
as an alloy with 6% aluminum and 4% vanadium (Ti-6Al-4V). CPTi has been used since
1950 in medical applications due to its superior mechanical strength, corrosion resistance,
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its welding ability and ease for shaping. CPTi alloys (monophasic-α) are available in four
grades with disparate amounts of impurities of carbon, hydrogen, iron, nitrogen and
oxygen. In spite of relatively small percentages of the interstitial impurities, they affect
the mechanical properties of CPTi significantly. The limitations of CPTi lead to the
development of biphasic α/β alloys (Ti-6Al-4V), which are currently the most commonly
used alloys for medical applications.10
Titanium is considered biocompatible due to its low dissolution rate and non-reactivity of
the titanium-dissolution products leading to bone thriving and osseointegration.12,13
Topography of the titanium surface can be modified, mechanically or chemically, to
improve the rate and quality of osseointegration and to maximize bone-implant
interaction such as sand blasting, plasma-spraying and chemical treatment of the implant
surface.1,7,10,13 However, some titanium’s modifications (e.g. screw threading or
deposition of coating) will reduce its fatigue strength. Many studies believed that
bioactive coatings on dental implants might disrupt the inter-facial attachment with
bone.10,14-16
Under physiological conditions, titanium-based implants are in a passive state because of
the thin layer of titanium oxide, of nm thickness, that is formed immediately over implant
surfaces. This layer will be in contact with the tissues of the body. The superior corrosion
resistance, biocompatibility, and osseointegration of titanium were ascribed to the
presence of this layer.17 Different oxides such as TiO, TiO2, and Ti2O3 can be formed.
Yet, TiO2 is considered to be the most stable oxide and usually is found after exposure to
physiological environments. The crystalline structures of the oxide layer are changed
according to implant surfaces.1,7
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Even though titanium is considered as a material of choice for dental implants, its
limitation has been investigated in several studies. Despite the long-term clinical success
rate (10-16 years) of titanium dental implants, biological and technical complications did
occur (48.03% up to 16 years).18,19 Sicilia et al19 found that diverse titanium allergic
reactions were detected in some dental implant patient. Other studies and clinical reports
addressed the relationship of titanium dental implant failures to allergic and
hypersensitivity reactions, in spite of the deficiency of epidemiological studies.18-23
Additionally, the cosmetic outcome of anterior dental implants might be unacceptable to
the patients due to a greyish dark color line along the gingival tissues as a result of
gingival resection or thin peri-implant gingival tissues.24

1.1.2.2 Ceramics
Ceramics exhibited outstanding biocompatibility, owing to their chemical stability. The
color of ceramics can match the color of bone, enamel and dentin. Ceramic implant
materials are classified into two categories: “inert” and “bioactive”.1
Bioactive ceramics react directly with bone tissue; the result of this reaction is a direct
chemical bond between the implant surfaces accompanied with new bone formation.25
Bioactive ceramics are relatively brittle and partially soluble, making it not suitable for
use in high-stress situations. Therefore, it is mainly used as bone filler or as surface
coating. There is a great emphasis on bioactive and bioresorbable ceramics to elicit
normal tissue regeneration and form an intimate bond with bone tissues.1,7
Hydroxyapatite,(HA), Ca10(PO4)6(OH)2 and tricalcium phosphate (Ca3(PO4)2) are some of
the commonly used bioactive ceramics, which can possibly develop a cohesive chemical
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bond with bone.26 Accordingly, ceramic materials can be used as a coating onto other
implant surfaces or it can make up the bulk of dental implant.
Inert ceramics like aluminum oxide (Al2O3), carbon (C) and zirconia (ZrO2) are well
tolerated by bone tissues similar to titanium-based alloys.7 Inert ceramics have high
strength, stiffness and hardness, but their fracture resistance is poor, especially to bending
forces. Inert ceramics can withstand relatively low tensile and shear stresses, with the
high risk of catastrophic fractures.7,17 Several forms of carbon have been used including
amorphous carbon, carbon fibers and carbon-silicate, but currently they are not used
because of their defective osseointegration. Alumina, one of the inert ceramics, is brittle
and tends to break when subjected to occlusal forces.17
Zirconia is the oxidized form of zirconium (ZrO2). Currently it is the only used allceramic dental implant material, owing to its outstanding mechanical properties
comparable to that of steel, in particular bending strength, fracture toughness, and
Young's modulus. Zirconia has been used as implant biomaterial for hip replacement
since the 1970s.24 In Dentistry; zirconia has been used widely for different applications
such as manufacturing high strength crown and bridge frameworks, endodontic posts,
implant abutments, veneers, and orthodontic brackets.7
The first in vivo study of zirconia dental implants was in 1993, when a group of
researchers inserted experimental zirconia in the mandibles of dogs.27 However, the first
clinical report of using zirconia dental implant in patients was published in 2004.28
Zirconia dental implants showed satisfactory osseointegration that is comparable with the
titanium dental implants,29 and the stress distribution is also similar to that of titanium
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implants.30 Other study revealed that the fracture strength of the one-piece zirconia
implants can be reduced following machining and during cyclic loading.31 Nevertheless,
the current clinical data on the biomechanical behavior of the zirconia dental implants are
inadequate.31,32 Currently zirconia is used for different application ranging from dental
implant abutment, one-piece dental implant, dental posts and in hip arthroplasty (Figure
1-2).

Figure1-2: Clinical applications of zirconia. A) Dental implant abutment.
dental implant.

34

33

B) One-piece

C) Different generations of zirconia used in hip arthroplasty as bearing

materials.35 D) Zirconia-containing glass-ceramic ingots and zirconia posts.36 Figures are
adapted from the references with permission (Appendix A)
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Zirconia is a polymorphic material since it can have more than one crystalline structure
depending on the pressure conditions and temperature. Pure zirconia is monoclinic at
room temperature (RT). As the temperature increases, the monoclinic phase transforms
into the tetragonal form at 1170 °C and later into the cubic phase at 2370 °C.37 As the
temperature cools down to RT, phase transformation is accompanied with significant
volumetric expansion (3-5 vol %) generating high internal stresses and cracks in pure
zirconia.28,38
Metal oxides such as CaO, MgO, CeO2 and Y2O3 were added to pure zirconia, in small
percentages (3-8 mass%), to stabilize the tetragonal phase at RT by allowing the
generation of multiphase materials and to control the volumetric expansion.38 Yet, the
majority of dental researches focused on Y2O3 doped zirconia, which is known as yttrium
tetragonal zirconia polycrystals (Y-TZP).38 Y-TZP exhibits diverse interesting
characteristics like high density, high compression and bending strength as well as low
porosity that is usually associated with other oxides such as MgO.37 The addition of small
percentages of Y2O3 to zirconia results in the formation of a metastable tetragonal crystal
structure at RT. When a crack is generated, it tends to progress and grow. In the
meantime, the metastable tetragonal crystal structure of zirconia transforms to the more
stable monoclinic form accompanied by an expansion of the material causing closure of
the crack tip and consequently preventing it from advancing.39 This phenomenon is
known as stress-induced transformation toughening which gives Y-TZP ceramics its
superior mechanical properties compared with other ceramics.
On the other hand, the ongoing progression of phase transformation might initiate surface
flaws, followed by the ejection of grains, resulting in catastrophic effects and making the
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material more vulnerable to aging.40 Additionally, Y-TZP undergoes microstructural
degradation at a relatively low temperature in humid environments leading to a significant
decrease in flexural strength41 and reducing its functional lifetime as a result of increasing
the susceptibility to crack growth.42
Many researchers are concerned about the considerable concentration of radioactive
impurities of uranium and thorium radionuclides in naturally occurring zirconia.43 Alpha
and gamma radiations are correlated with zirconia. Significant alpha radiations have been
detected in zirconia-based ceramics used for surgical implants that can adversely affect
hard and soft tissue cells.27 Gamma radiation levels are not considered hazardous in
zirconia.43,44 Since the radioactivity of Y-TZP ceramics can be effectively managed by
carefully controlled purification procedures, Y-TZP can be safely considered for
biomedical applications.24,43 Many published papers state that the radiation doses from
highly purified zirconia powder ceramics form are significantly lower than the natural
background dose.40 Zirconia can be used as a dental implant by itself, or its particles can
be used as coating materials for titanium dental implants to improve its
osseointegration.45

1.1.3 Mechanical Parameters of Dental Implant Materials
Dental endosteal implants are used to reconstruct and replace missing teeth to improve
mastication, aesthetic and speech, stabilize and support removable dentures or create the
abutments for fixed prostheses.11 Therefore, the bone-implant interface should withstand
forces generated during functional and para-functional forces for up to 40 years.17 The
magnitude and spatial distribution of stresses on the implant, bone and the dental implant-
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tissue interface will depend on several factors: dental implant shape, loading on the
implant, quality and quantity of the surrounding bone and the mechanical properties of
implant and interfacial bony tissues.46 Listings of the materials’ physical properties are
not useful unless they are related to the physiological implications of the biomechanics.47
Implants are subjected to compression, shear, bending and torsion loading leading to a
wide range of normal and shear stresses. The force direction must be considered in
addition to the magnitude of the loading. Since bone is 65% weaker when loaded in shear,
shear forces that are transmitted from implant to bone should be reduced.13 Increased
interfacial shear strength results in a better stress transfer from the implant to the
surrounding tissues and lowers stresses in the implant.48 Studies have shown that
excessive forces compromise the osseointegration and biointegration of the implants.17
The occlusal forces are transferred from teeth to the surrounding bone via periodontal
ligaments as tensile and compressive forces that favor the maintenance of the bone
support by balancing between bone apposition and resorption in a process known as bone
remodeling.49 On the other hand, the occlusal loads from the dental implants are
transmitted to the bone tissues mainly by compressive forces that tend to cause bone
resorption.4 Modifying the material type, diameter and length of dental implants are
considered as important factors to reduce the compressive forces in addition to the
patients’ factors including occlusal habits (clenching and bruxism) and the quality of the
jawbone.17 Moreover, threaded dental implants have the tendency to reduce shear stress,
convert occlusal loads into more favorable stresses at the bone interface, and reduce the
risk of failure.13
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During normal functioning, dental implants are subjected to various forces and moments
that are transmitted to its internal structure. Thus they should tolerate these different
masticatory loads without failures or fracture.50 However, a quantitative evaluation of
these loads is challenging, because it is determined by several factors such as magnitude
of the usual chewing forces that range between 220-880 N, anatomical and physiological
properties of surrounding bone and the mechanical properties of the dental implant.50
Modulus of elasticity, fracture toughness, fatigue strength, yield and ultimate strengths
are the more important mechanical properties for dental implant design.1 In the current
research project, we evaluated the modulus of elasticity and fracture toughness of the
bioceramics that we synthesized.

1.1.3.1 Modulus of Elasticity
The young’s modulus of elasticity (E) is an expression for material stiffness and an
important property that influences the ability of the implant to transmit stresses to the
adjacent bone and sustains tissue vitality over time.1 It affects osseointegration and
implant’s compatibility with surrounding bone.51 The Young’s modulus for titanium and
dental zirconia are 100-116 GPa10 and 200-210 GPa52, respectively. These values are
significantly higher than that of the human cortical bone ranging from 4 to 30 GPa.10,11,53
The extreme mismatch between the E values, of bone and implant materials can lead to a
phenomenon known as stress shielding. As a result of the extremely stiff implant, disuse
atrophy, bone resorption and implant complications can occur.54-56 The E value is used to
evaluate bio-functionality of dental implants. The lower the Young’s modulus of implant
material, the better the load distribution to the surrounding tissue with the possible

12

beneficial result of new bone formation.11 Porous titanium dental implants are used to
decrease the E value, but the fatigue strength was diminished by at least 10%.11

1.1.3.2 Fracture Toughness
The fracture toughness (KIC) is a measure of energy needed to cause failure in the
presence of a defect and it is important in evaluating implants with surface contours that
can act as stress raiser.1 KIC is a critical value of the stress-intensity factors that causes
failure of the material. KIC values of materials are most useful when working with
materials of limited toughness or ductility. Materials that show very little plastic
deformation before fracture usually have relatively low KIC.57 Improvement of KIC values
of the dental implant materials have been established by various surface modification
approaches, such as flaw modification (size or geometry), coating and heat treatment.58
The microstructure of the materials has a considerable effect on the KIC. For instance,
dense interlocking crystals microstructure usually attributes to higher KIC as a result of
blunting microcracks and inhibiting crack propagation.36
KIC is usually measured using a four-point bend test with a single-edge or chevronnotched specimens or by compact tension through recording the tensile or bending force
repectively59. Another method for calculating KIC is Vickers indentation tests.57,60 The
Vickers indentation test has become common for brittle materials like glasses and
ceramics because it is simple, quick, standardized by using Vickers diamond indenter and
it can be used on a comparative basis for specimens with small surface area.60 Yet, there
are limitations to this technique including:
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1. Presence of 19 different standardized equations in the literature to calculate KIC. These
equations are assuming the crack geometry as radial-median (halfpenny) or Palmqvist
shaped.60
2. Measurement of the crack length, that is used later to calculate the KIC, should be
accurate and standardized.60
3. Young’s modulus and hardness of the material should be known to be included in the
KIC equation.57,61
Blendell, Evans and Lankford equations applied curve-fitting methods for median and
Palmqvist crack patterns, which were applicable to both cracks systems.57 In my thesis
research, the Lankford equation was used to calculate KIC since it combines both crack
geometries.

1.1.3.3 Fatigue Strength
Dental implant materials can fail at a much lower stress, when subjected to cyclic
loading, than that which the material can withstand under the application of a single
maximum load. These failures are known in engineering terms as fatigue failures, while
they are identified in clinical fields as stress fracture. Stress concentration (often known
as stress raiser or stress riser) is the localization of high stresses at sharp notches, holes or
corners, it is often the point of originating fatigue failure.62 Once initiated, the crack can
propagate incrementally within the material under the cyclic or repeated loading.59 Since
fatigue fracture of dental implants does occur, fatigue resistance is considered an
important property of dental implants. The most severe mechanical stress conditions are
related to biodynamic fatigue when several factors are involved such as the surface
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topography and presence of stress concentration and corrosive environments.59 ISO
14801 standard was introduced to test the dynamic fatigue strength of dental implant
materials with angled specimens to determine the survival functional threshold loads
under “worse case” biological conditions.50 Interestingly, it has been proven that fatigue
strength especially due to fretting (where an overlapping of friction wears and cyclic
loading occur between two bodies such as a screw and bone plate) was higher when the
materials exhibited low Young’s modulus.63 The passive oxide layer on titanium alloys
can crack when bending forces were applied on the implant leading to corrosion fatigue
in simulated body environments that accompany low oxygen content and degassing with
nitrogen.64 It was proven that the fatigue strength of dental implants decreased by 19% in
simulated body environments compared with the laboratory dry conditions. Furthermore,
corrosion fatigue can be initiated with the development of pits that act as sites of stress
concentration.65
Fatigue failure is infrequent in ceramics owing to the absence of inelastic (plastic) strain
during cyclic loading.59 However, inter-granular fatigue can cause reduction of
mechanical strength as a result of the propagation of natural microcracks originally
existing in the component’s microstructure. Although Y-TZP ceramic materials show
significant subcritical crack propagation at extensively lower stress levels, but it could be
used successfully in dentistry subjecting to the masticatory forces taking into
consideration its initial high mechanical strength and special design of the material.66
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1.2 GLASS-CERAMICS
Glass-ceramics (GC) were first discovered in mid-1950s by a famous glass chemist, S.D.
Stookey36 who found that these materials combined the attractive properties of glasses
and ceramics on top of the favorable properties superior to organic polymers and
inorganic materials.36 Later, in the late 1950s, Corning Glass Works developed diverse
GCs for different applications.39 MacCulloch7,39 in 1968 introduced the first dental GC
based on the Li2O-ZnO-SiO2 system that was used to construct denture teeth. He
suggested the possibility of using this GC to fabricate crowns and inlays by centrifugal
casting of molten glass.39
GC is a ceramic material formed by a process called ceramming. This process involves
subjecting base glasses to controlled heat treatment, during which nucleation is initiated
followed by the development of tiny and evenly distributed crystals throughout the glass
structure. The crystalline phase will grow and can eventually occupy from 50% to nearly
100% of the material.7,39 Thus, a GC is a multiphase material containing a residual glass
with a finely dispersed crystalline phase(s).39 The number and size of the crystals and
their growth rate are regulated by the ceramming time and temperature of the heat
treatment. GCs have a wide variety of special microstructure that cannot be produced in
any other material. These microstructures are related to the base glass, structure of the
formed crystals and their mode of growth.39 Currently, GCs based on leucite, lithium
disilicate and HA have been used for dental applications. They are available as powders
or as solid blocks that can be pressed, milled or prepared using computer-aided
design/computer-aided manufacturing (CAD-CAM) technology.
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1.2.1 Glass-Ceramic Properties
GCs with diverse and favorable properties were developed based on the chemical
composition of the base glass and the microstructure of the GC. Regarding the processing
properties; synthesis of parent glass is considered as a critical step in the GC
development. In addition to producing bulk glasses by traditional melting and forming, it
can be produced by sol-gel, chemical vapor deposition, rolling, spin-casting, thin-layer
method, casting, drawing, pressing and press-blowing a glass melt. Technologies used to
synthesize the base glass can be used for the production of the GC. Glass powder or
grains can be converted to GCs by different methods. GCs are thermally stable; they can
withstand high-temperature with limited and controllable shrinkage and expansion. Thus,
GCs are manufactured on a large scale for industrial, technology and medical
applications.36
As GCs are non-porous and multi-phase materials, they demonstrate different levels of
translucency, transparency, and opacity based on the type of crystals, microstructure of
the material and the difference in the refractive index between the crystal and the parent
glass.67 GCs can be produced in any color by adding pigmentation. Other important
optical properties for some GCs are fluorescence and opalescence.36
Degradable or chemically durable GCs can be produced depending on their crystals, the
glass and crystalline phases exist in the material and the interface between the crystals
and the glass phase. Different microstructures of GCs permit the combination of
resorbability of one specific phase and chemical stability of other phase(s). Some GCs
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have good biocompatibility and have been developed for medical and dental applications;
other GCs are bioactive and used in implantology.68
The mechanical properties of GCs are improving; it has been possible to achieve flexural
strength up 500 MPa and KIC higher than 3 MPa·m0.5. Flexural strength (also known as
bend strength, fracture strength or modulus of rupture) is the material’s ability to resist
deformation under load when unsupported, while the fracture toughness is the estimation
of the load required to cause crack propagation.62 No other material exhibited excellent
mechanical properties combined with translucency and handling qualities as in the case of
monolithic GCs. An additional advantage of certain GCs is their machinability, where the
material can be milled, drilled or sawed into different shapes.69 Furthermore, surface
characterization of the GCs such as roughness, polishability, luster or abrasion can be
controlled.68 There are different GC systems, which are available in the market for
medical or dental applications such as wollastonite, leucite, lithium disilicate, HA and
mica GCs. Other GC systems are discussed in the literature but they are still not available
for clinical applications such as miserite, fluorrichterite, fluorapatite and canasite GCs.36

1.2.2. Medical Glass-Ceramics
GCs are used in implantology as medical prostheses to replace missing parts of body such
as orthopedics, head and neck surgery, dental implants and root fillers. These materials
should be biocompatible, and in most cases, bioactive to form a biologically active
hydroxycarbonate apatite (HCA) layer that permits bonding with bone. Depending on the
application, GC can be load bearing or non-load bearing to fulfill different requirements
for each situation with respect to bending strength, toughness and Young’s modulus.36
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Bioactive glasses such as BIOGLASS® was found to have multiple applications and are
used in head and throat surgery in the form of middle-ear devices and implants for orbital
floor of the skull.25 The following bioactive GCs are used in human medicine for
implantology: Cerabone®, Ceravital® and Bioverit®.
Cerabone® is a GC prepared from the parent glass in 3CaO.P2O5-CaO.SiO2MgO.CaO.2SiO2 system. Both of, apatite (A) and wollastonite (W) crystalline phases are
homogeneously distributed in a glass matrix, commercially known as cerabone®A-W.70
Cerabone®A-W is the most widely and successfully bioactive GC used for bone
replacement in human medicine.36 Since 1983, A-W GC has been used in spine and hip
surgery, in the form of vertebral prostheses, for iliac crest restorations70 or as bone defect
fillers.36 A-W GC demonstrates high bioactivity.70 The advantages of this GC provided by
the combination of bioactivity and specific mechanical properties, such as compressive
strength (215 MPa), Young’s modulus (110 GPa) and KIC (2 MPa·m0.5).36 The GC can be
used in non-bearing load areas, and it was successfully used for vertebra replacements in
more than 10,000 patients between 1991-1996.36
Ceravital® Apatite-devitrite GC contains mainly SiO2, Ca(PO2)2 and CaO with small
amounts of oxides such as Na2O, MgO, K2O.70 In vitro and in vivo investigations have
proven the biocompatibility and bioactivity of ceravital® GC.71,72 However, because of its
poorer mechanical properties, the only clinical application for this material is the
replacement of the ossicular chain in the middle ear where the loads are minimal.36,70
Bioverit®I is a mica-apatite GC with a chemical composition derived from the SiO2Al2O3-MgO-Na2O-K2O-F-CaO-P2O5 base glass system. Bioverit®II GC contains mica as
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the main crystal phase. Bioverit®III is SiO2-free, contains apatite, AlPO4 and complex
phosphate structure.70 All these GCs are machinable and workable with standard metal
tools and they can be modified during the surgical procedure. The machinability of these
GCs depends on mica content and the morphology of the GCs – the higher mica contents
the better machinability of the GC.36 Adequate mechanical properties of Bioverit®I and
Bioverit®II allow them to be used as medical bone substitution for different applications
such as orthopedic, head and neck surgery especially middle ear implants. Bioverit®III is
used in composites with certain metals as bioactive materials.70

1.2.3 Dental Glass-Ceramics
Dental GC is the second category of GCs that used for restorative dental applications to
fulfill the dental biomaterial standardization. They must be capable of simulating the
natural teeth properties: show compatibility with oral environment, high strength,
resistance to abrasion and wear, and excellent chemical durability to withstand the harsh
oral circumstances of wide range of temperature and pH. Surface properties of the dental
GCs should match those of natural teeth like shade, translucency, opalescence and
fluorescence. Another important property of the dental GCs is their suitable handling
techniques for both dentists and dental technicians.73
Restorative dental materials are used to fabricate crowns, bridges, inlays, onlays and
veneers by different techniques such as casting, hot pressing, moulding, centrifuge
layering and sintering.74-76 The following dental GCs have these properties: Dicor®, IPS
Empress® Cosmo, IPS Empress®, IPS Empress® 2, IPS d. SIGN®, Pro CAD® and IPS
e.max.
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Dicor® was the first GC used for inlays and crowns production68 synthesized from SiO2Al2O3-MgO-K2O-ZrO2-CeO2 glass system.36 The main crystalline phase present in this
GC is tetrasilicic mica crystals produced by controlled volume crystallization. Crystals
are 1 µm in length at approximately 55 vol %.75,77 Dicor® is a castable GC with which
dental restorations are fabricated in the dental laboratory in a centrifugal casting
procedure.68 The optical quality of DICOR® produced by controlled translucency is based
on the microstructure of mica crystals embedded in a glassy matrix.36 There is a
relationship between the clinical survival of Dicor®GC dental restorations (up to 20 years)
to various physical and biological factors, such as tooth position, patient sex, core
structure, acid etching and cementation.78
Dicor®MGC is a machinable GC, where the dental restorations are produced using CADCAM technology. This GC is characterized by a high crystallinity, approximately
70 vol % of crystal content. The main crystalline phase is tetrasilicic fluromica,
KMg2.5Si4O10F2, in a sandwich-like composite sheet.36,74 Interlocking, easily cleavable
fluoromica flakes of average diameter of 2 µm and 0.5 µm thickness, are the key
machinability factors in the microstructure of Dicor®MGC.36,69 Dicor®MGC have
excellent properties, yet their clinical application is limited due to low KIC
(1.5 MPa·m0.5)79 and low biaxial flexure strength (150 MPa).80
IPS Empress®Cosmo is used for dental core construction where its strength is improved
by incorporation of more than 15% ZrO2 in P2O5-SiO2-Li2O-ZrO2 base glass. The
properties of GCs are influenced by the growth and formation of ZrO2 rich (Li2ZrSi6O15)
crystals during the hot-press procedure. These GCs demonstrate a bending strength of
maximum 160 MPa

with

high

translucency.81

Two

different

materials:

IPS
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Empress®Cosmo and ZrO2-sintered ceramic (CosmoPost) are used as a unique
combination to form post and core for endodontic treated teeth. The advantages of using
post and core combination include: improved esthetics, unified post and core, inert and
stable materials, high bending stiffness resistance to fatigue loading and simple
fabrication procedures.82
IPS Empress® is an extremely homogeneous, leucite-based material (KAlSi2O6)
fabricated from the SiO2-Al2O3-K2O base glass system using surface controlled
crystallization.74 The degree of crystallinity of IPS Empress®GC is 35±5 vol %.83 Leucite
crystals increase flexural strength of the GC; the GC exhibited biaxial flexural strength of
110-160 MPa36,83 and KIC up to 1.3 MPa·m0.5.83 Flexural strength value can be increased
to 200 MPa, by improving the surface quality74 or by modifying its microstructure.84 The
GC demonstrates very good chemical durability, optical properties (Figure 1-3A),
abrasion and wear resistance qualities, that are comparable to those of natural teeth.76
From 1991-2004, this GC was used to produce 27 million dental restorations, and the
success rate was higher than 90% over 14 years of clinical assessment.68 However, the
fracture rates were higher for posterior crowns than the anterior ones for different time
periods ranging between 5-11 years.76,85 Consequently, IPS Empress® is recommended
for producing metal free dental restorations such as inlays, onlays, crown and veneers, but
not recommended for multi-unit dental bridges.36
IPS Empress®2 is a pressed GC with lithium disilicate (Li2Si2O5) crystal phase. It was
developed in order to overcome the limitations of IPS Empress®, by increasing its
strength and toughness to extend the clinical applications to posterior multi-unit bridges.75
The pressed GC is derived from the basic SiO2-Li2O system with other oxides additions
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such as ZnO, P2O5, K2O and La2O3. It is fabricated through a combination of the lost-wax
and heat-press techniques. The GC has high crystal content (Figure 1-3B). Lithium
disilicate crystals are precipitated in the base glass by epitaxial nucleation and
crystallization until they reach up to 70±5 vol %, with randomly oriented interlocking
microstructure that are attributed to its superior mechanical properties.9 The interlocking
crystals deflect and blunt the developing cracks leading to increasing the toughness of the
material75 and substantial increasing in the flexural strength.39 The mechanical properties
of lithium disilicate GC are double or triple those of leucite GC.83 The flexural strength
value of IPS Empress®2 is around 400 MPa and the KIC is about 3.3 MPa·m0.5.83
Moreover, the chemical durability of this GC is within the ISO requirements of dental
ceramics and it is better than IPS Empress® GC by about fourfold.83.Though, the GC
cannot be machined or cut after pressing.68
IPS e.max Ceram is a low fusing nano-fluorapatite GC, and it is applied as veneering of
restoration produced by press technology and/or CAD-CAM technology to improve its
optical properties. Apatite needle-like crystals can be precipitated in SiO2-Al2O3-CaONa2O-LiO2-K2O-P2O5-F system.68 The abrasion characteristics of the fluorapatitecontaining GC are similar to lithium disilicate GC, but its chemical durability is higher
than IPS Empress®2. Dental restorations can be fabricated in a special combination
design; framework made of the high strength GC to absorb the load peaks, and the veneer
apatite GC to produce optical properties such as fluorescence and opalescence with
excellent chemical durability.36
IPS d.SIGN®: a leucite-apatite composite containing GC derived from the SiO2-Al2O3Na2O-K2O-CaO-P2O5-F system. This GC is developed by combining two different
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mechanisms: controlled surface nucleation that precipitates leucite crystals, and controlled
bulk nucleation that precipitates fluoroapatite crystal phase, Ca5(PO4)3F.68 It is used to
veneer metal framework of multi-unit bridges owing to the combinations of appropriate
translucency, color, and brightness, with proper mechanical and chemical properties.75
This GC is the most frequently used GC materials; around 55 million units were clinically
delivered from 1998-2004.68 IPS d.SIGN® GCs can be presented in different categories
according to their usage to restore different tooth structures.36

Figure 1-3: Dental applications of glass ceramic A) IPS Empress®GC inlays and veneer.
B) IPS Empress®2 (3 unit bridge, crown, veneer and inlay). Adapted with permission
from Glass-Ceramics Technology.36 (Appendix A)

1.2.4 Machinable Dental Glass-Ceramics
CAD-CAM has become a commonplace fundamental technology in an industry used to
design and fabricate virtually various products such as automobile, airplanes and jet
engines.86 CAD-CAM was introduced to dentistry in 1970s, followed by the development
of CEREC® system in 1980s.87 CAD-CAM provides advanced, highly qualified, state-ofthe-art services to dental patients.88
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Machinable dental materials can be milled into their final form without condensation,
sintering or melting. For direct restoration, a camera scans the replica of the prepared
tooth to produce digital impression. Data are processed to software that guides machining
tools to mill the ceramic blocks to the final restorations within a short time. Dental
restorations are delivered in a single clinical appointment minimizing postoperative
sensitivity and preventing tooth contamination. In the most advanced techniques, captured
digital impressions are sent electronically to the lab for milling and production of the
restorations. CAD-CAM restorations have several advantages over other restorations.
First, shrinkage is not associated with CAD-CAM restorations due to the absence of
heating, casting, condensing and melting. Second, the properties of the restorations are
more predictable because of the machinable dental blocks.17 Currently, the innovation of
CEREC®3 system is reflected in technical improvement of processing quality of ceramic
restorations that are produced with natural morphology, fine surfaces and improved
adaptation to the restored teeth.89
ProCAD®: is a leucite-reinforced GC derived from the system SiO2-Al2O3-K2O-Na2O,
similar to IPS empress® with a finer particle size. It is characterized by excellent chemical
durability, outstanding esthetic outcomes with different degrees of translucency that is
available in several shades.90 Mechanical properties of ProCAD® are acceptable, KIC was
determined to be 1.3 MPa·m0.5 with flexural strength of 135-160 MPa, that may be as high
as 180-240 MPa after polishing the restoration surface or applying ProCAD® glaze.36
IPS e.max®: is a machinable lithium disilicate GC that can be used with CAD-CAM
systems. An intermediate lithium metasilicate GC containing dendritic crystals was
developed, where the crystals are smaller and more homogenous than lithium disilicate.91
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Lithium metasilicate GC is blue in color, and it can be machined easily and quickly to
produce dental restorations which subsequently are heat-treated at 850 °C to be converted
into a lithium disilicate GC. Subsequently, the restorations are additionally veneered with
a fluoroapatite GC to imitate the optical properties of natural teeth.92 Clinical studies
reviewing IPS e.max® dental restorations showed up to 8 years survival rates up to 93%
for dental crowns and small bridges.93 Other clinical studies disclosed that IPS e.max®
all-ceramic three-unit bridges exhibited survival and success rates comparable to those of
metal-ceramic bridges.91

1.3 BONE PROPERTIES FOR DENTAL IMPLANTOLOGY
Bone is a highly organized, mineralized connective tissue that has fundamental physical
functions. It is one of the few mammalian tissues that can resist compressive and shear
loading. Because of its stiffness and rigidity, it is suited for different functions including
locomotion, standing and withstanding the mastication forces that can reach 1000 N.94
Two primary functions are provided by bone: mechanical and metabolic. From the
mechanical point of view, bone supports different structures and organisms, protects vital
organs such as brain and heart and acts as leverage for musculoskeletal locomotion.95
Bone consists of a biphasic extracellular matrix (ECM), cells, blood vessels and nerves.
Bone matrix is composed of 30 vol % organic and 70 vol % inorganic materials.96 The
organic part consists mainly (98%) of a network of collagen type I fibers that contribute
to tensile strength and toughness.97,98 The remaining 2% of the organic content includes
structural and biologically active proteins, glycoproteins, peptides, lipid materials and
adsorbed serum proteins.95 The inorganic portion of bone ECM is composed of minerals,
primarily carbonated hydroxyapatite, that include a complex of calcium phosphate,
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calcium carbonate and small amounts of calcium fluoride and magnesium fluoride4 that
contribute to compressive and shear strength and hardness.97 The crystals in bone are
small (an approximate diameter of 25-75 Å and length of 200 Å), and primarily presented
in the form of poorly crystalline carbonate-apatite structure.95

1.3.1 Macroscopic Structure of Bone
The mammalian skeleton is composed of two distinct kinds of bone based on porosity:
dense cortical bone (also known as compact bone) and trabecular bone (also known as
spongy or cancellous bone). Both cortical and trabecular bone are found in every bone
site, but their quantity and distributions vary. The non-mineralized spaces within
trabecular bone contain marrow, blood vessels, nerves and various cells. The main
function of marrow is to generate the cells present in blood. Marrow is a highly
osteogenic tissue that can lead to bone formation if placed in extracellular skeletal
locations.4
Dense cortical bone comprises about 80-85 vol % of total bone in the body, it forms a
shell around vertebral bodies and most bones. Cortical bone has two surfaces: outer
periosteal and inner endosteal surfaces49 (Figure 1-4). Cortical bone is organized in bony
cylinders consolidated around a central blood vessels, called a Haversian system or
osteon.4 The structure and microstructure of cortical bone provide the principal
mechanical strength of the skeleton; the cortical thickness and cross sectional areas are
strong indicators of gross bone strength and fracture resistance.97 Trabecular bone
comprises about 15-20 vol % of the body’s total bone, is found in cuboidal, flat bones and
in the end of long bones. When compared with cortical bone, it is lesser in density and
has a greater degree of macro-porosity (medullary cavities) that is interconnected and
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filled with hematopoietic marrow or fatty marrow in older adults.
Periosteum, the outer surface of cortical bone, forms a boundary between bone tissue and
the covering soft tissue. The endosteum is fibrous and delicate membrane consisting of
progenitor cells with slight amount of connective tissue. It acts as a lining of medullary
and inner cavities of bone. Periosteum and endosteum are the sites of metabolic, cellular
and biomechanical activities that modulate bone growth and shape.49 They also contribute
to new bone formation in the case of bone fracture.96
Wolff’s law stated that there are specific strain values that maintain the form and mass of
the bone; values above this range will stimulate bone apposition while strains below the
maintenance limit lead to bone resorption.99 A study showed that these dynamic changes
in the alveolar ridges primarily occur in cortical bone.100

1.3.2 Bone Cells
A brief overview of bone cells is provided in the thesis because knowledge of the role of
different bone cells and matrix molecules in bone formation and resorption is important
for understanding the body’s reaction to dental implants. This knowledge is helpful for
evaluating the biological performance of different materials used as dental implants.
Three major types of cells are involved in bone metabolism and physiology: osteoblasts,
osteocytes and osteoclasts (Figure 1-5).
Osteoblasts are mononuclear, cuboidal and highly secretory cells. They are derived from
multi-potential mesenchymal progenitor cells; mesenchymal stem cells or marrowderived stromal cells.95 Mature osteoblasts are responsible for producing bone’s organic
matrix that subsequently mineralizes extracellularly.101
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Bone deposition continues in an active growth area, with osteoblasts laying down new
bone in sequential layers. Osteoblasts produce phospholipids and proteoglycans that are
important in the mineralization process.4 They produce paracrine growth factors that
influence osteoprogenitor cells, the growth of preosteoblasts, and resorption of the
mineralized bone matrix by osteoclasts during bone remodeling.95 Mature osteoblasts
affect osteoclastogenesis that in turn controls the degree of resorption at different bone
sites.103 Moreover, osteoblasts may act as helper cells for osteoclasts during normal bone
resorption.4 When osteoblasts have successfully produced bone matrix, a fraction of
osteoblasts that had become embedded transform into osteocytes, while the majority of
the cells undergo programmed cell death (apoptosis).95
Osteocytes are mature, post-synthetic osteoblasts; they are the most abundant bone cells
(90-95% of all bone cells) and are the longest living type of bone cell.104 Osteocytes are
involved in mineral homeostasis95 and coordination of metabolic activities.104 Osteocytes
act as mechanosensory cells by responding to internal and associated local strains from
external loads on bone and, thus, osteocytes help to sustain the ECM.96 Mechanical
stimulation regulates gene expression in osteocytes, and affects their survival and
apoptotic death. Some studies indicated that osteocyte apoptosis might stimulate or inhibit
signals regulating the localized function of osteoclasts and osteoblasts.105 Additionally,
osteocytes can induce osteoclast activity, where the osteocytes orchestrate bone
resorption as a result of expression of a rate-limiting factor required for osteoclast
formation and function.104,106
Osteoclasts are large motile, multinucleated cells (containing as many as 50 nuclei), and
are responsible for bone resorption.4 They originate from hematopoietic stem cells in the
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non-adherent part of the bone marrow.107 Osteoclasts are located in shallow excavations
(Howship’s lacunae) along mineralized bone surfaces.4 The mechanism of the
osteoclastic bone resorption is unique and efficient. Bone resorption requires a number of
steps: 1) migration of osteoclast precursors to the bone surface; 2) fusion of precursors to
form multinucleated osteoclasts; 3) attachment of the osteoclast to the bone surface; 4)
polarization of the osteoclast to form three distinct membrane domains – a ruffled border,
a sealing zone and a functional secretory domain; 5) pumping of HCl to lower the pH in
the resorption lacuna, leading to dissolution of bone mineral; 6) secretion of hydrolytic
enzymes to degrade the organic phase of the bone matrix; and 7) removal of degradation
products from the resorption lacuna. Afterwards, osteoclasts undergo apoptosis or return
to the non-resorbing stage.108
In healthy adults, there is a continuous balanced interaction between bone-forming
osteoblasts and bone-resorbing osteoclasts to sustain skeletal remodeling and maintain
bone mass. Discrepancies of this balanced relationship are a feature of pathological
disorders such as osteoporosis.95
Bone-lining cells are a fourth type of bone cells. They are retired osteoblasts that do not
embed in newly formed bone like osteocytes; instead, they adhere to the outer bone
surfaces. Bone-lining cells are responsible for regulating the transfer of mineral ions in
and out of bone, for sensing mechanical strains and for initiating bone remodeling in
response to various chemical or mechanical stimuli.4 Bone-lining cells also have
important function of cleaning bone surfaces before osteoclastic resorption.109
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1.3.3 Bone Related Markers and Adhesion Proteins
Different ECM molecules and other proteins have been proposed in the literature as bone
markers. Cell-dental implant interactions such as cell attachment, adhesion, proliferation
and differentiation involve collagen I, alkaline phosphatase, osteopontin, and bone
sialoprotein.110 It is important to understand the expression of specific bone-related
markers, involved in osteoblast development, osseointegration and dental implant
biocompatibility. Below, we briefly discuss the marker that was used in this thesis as well
as the adhesion proteins used to assess osteoblast attachment and spreading.
Alkaline phosphatase (ALP) is a hydrolytic enzyme that removes phosphate groups
from proteins and other types of molecules. It is present in bone (produced by
osteoblasts) and several other organs of the human body. ALP is a common biochemical
marker used to evaluate osteoblast differentiation111 and is considered as a sensitive and
reliable indicator of osteoblast activity.112 It can be bound to the surface of osteoblasts via
a phosphoinositol linkage and can be free floating within the mineralizing matrix.49 ALP
is abundant in matrix vesicles that are thought to contribute to ECM calcification113. The
levels of ALP are increased before bone mineralization to generate free phosphate
(needed for formation of HA) and to degrade mineralization inhibitors such as
pyrophosphate.111
Adhesion proteins: Cell adhesion on implant materials is required for successful
osseointegration of the implanted material. Moreover, cell adhesion to ECM is crucial for
modulation of numerous critical cellular events; examples include gene expression, cell
locomotion and subsequently cell differentiation, proliferation and survival.114 Cell
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adhesion is dependent on integrin-mediated signal transduction and cytoskeleton proteins
that form specialized structures known as focal adhesions (FA).111 At FA sites, bundles of
actin filaments are attached to transmembrane receptors of the integrin family. Some FA
components provide a structural link between actin filaments and membrane receptors.
Other components are signaling molecules including different protein kinases and
phosphatases, their substrates and many adaptor proteins. These complexes include focal
adhesion kinase, vinculin, integrins and actin filaments. 115
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Figure 1-4: Sections through the diaphysis of a long bone, from the periosteum on the
right, to compact bone tissue in the middle, to spongy bone tissue and the medullary
cavity on the left. The inset at the upper right shows an osteocyte in its lacuna.
Reproduced from Anatomy and Physiology: From Science to Life, 2nd edition with
permission of John Wiley & Sons, Inc.102 (Appendix A).
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Figure 1-5: Schematic view of a cross-section through the mandible. An outer cortical
shell encases the inner trabecular bone containing the hematopoietic elements. When
examined at higher magnification, as in the upper drawing, the various cellular elements
of bone (osteoblasts, osteoclasts, osteocytes and bone lining cells) may be identified.
Adapted with permission from Dental Implant, 2nd edition6 (Appendix A).
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1.4 OSSEOINTEGRATION OF DENTAL IMPLANTS
Osseointegration is the formation of a direct interface between an implant material
surface and the host bone tissues without intervening connective tissue.116 Brånemark117
developed the concept of osseointegration in the 1950s when he discovered the formation
of strong bond between bone and titanium. The bone-implant interaction and the
conditions that favor osseointegration depend on various factors: implant material,
implant design and shape, chemical and physical surface quality, status of the bone,
surgical technique, and mechanical loading conditions.118,119 For a successful
osseointegration, the implant must be inserted with a low-trauma surgical technique to
avoid bone overheating during preparation of the precise recipient site. Implant must be
placed with initial stability and should be non-functional during the healing period of 3-6
months.2
Interfacial micromotion is a periodic development of µm displacement of an implant
body relative to the surrounding tissue as result to a shear or tensile force.120 Micromotion
has destructive effects on osseointegration; it will replace the early bony healing process
by scar tissues through damaging the fibrin network and the new vasculature.121 The longterm osseointegration of dental implants relies on their placement within bone that has
adequate trabecular density, ridge height and width. Trabecular bone that is not
sufficiently dense will either fail to osseointegrate or lose its osseointegration over time.4
Many researchers showed that surface modification and roughness of dental implants
such as porous plasma-spray,26,122 sand blasting,122,123 ultraviolet treatment,124 acid
etching125,126 or anodic oxidation13 have direct effects on cellular proliferation and
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differentiation. Other studies revealed that porosity provides favorable environments for
bone interlocking and in-growth. Titanium implants with a micro rough surfaces
accomplish faster bone integration and superior percentage of bone implant contact with
shorter healing periods compared with titanium implants with a polished or smooth
surface.3,119,122,125 It has also been demonstrated that surface treatments such as
biomimetic coatings (e.g. calcium phosphate) promote greater osseointegration.14,116,125
Ceramic implants promote biointegration versus osseointegration that are related to
titanium-based dental implants. Successful osseointegrated/biointegrated dental implants
should show clinical stability without any kind of mobility that can be maintained
throughout the lifetime of the implant. Biointegration can be defined as the continuity of
ceramic implant to the surrounding bone without any intervening space.17 In this case,
corrosion products will enclose the implant surfaces and there will be a chemical bond
between the implant material and the bone.127
Biointegration, although not fully understood, is considered to be a chemical degradation
of the ceramic material that integrates with the surrounding bone and stimulates bone
formation. Yet, the advantages of biointegration over osseointegration are not clear, but in
both cases, surrounding bone should remain vital.17 To combine both osseointegration and
biointegration properties at the osteotomy site, plasma-spray coating of HA is used as the
most common method for surface modification of metallic dental implants with a coating
thickness of 50-100 µm.26,45,128 In this case a combination of high strength alloy and
favorable biointegrated characteristics of the ceramic material is achieved.17,25 These
bioactive coatings will enhance bone apposition and reduce healing time.129 Many studies
disclosed that these ceramic coatings promote greater bone-implant contact and
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biointegration rather than osseointegration and showed a greater bone-implant
contact.5,130,131
The bond strength of ceramic coatings to alloys is a significant concern. For example,
some studies have observed that non-uniform and partial degradation of the ceramic
coatings interferes with the cellular reactions at the implant-bone interface.132 Other
studies considered the coating dissolution as an adverse factor on the long-term
integration of the dental implants.129,133 Debonding of the coatings from the base alloys
could affect the long-term performance of the implant.14 The mismatch of the Young’s
moduli between the implant and the coating material can cause local loading with high
stress value at the interface leading to a reduction in the fatigue stress of the implant.65
It is advantageous to accelerate bone apposition onto dental implant surfaces because a
steady interface must be achieved before starting the implant loading. Different implant
surface configurations can improve the osseointegration, leading to the full transfer of
occlusal loads to the adjacent tissue and minimizing relative motion between implant and
bone to avoid creation of fibrous integration, thereby lengthening the service life of the
implant.13,118

1.5 BIOACTIVITY IN DENTAL IMPLANTOLOGY
There is a group of glasses and GCs that exhibit bioactivity by bonding to living bone
with the formation of an apatite layer. Bioactive materials are used clinically for the
replacement and reconstruction of bone defects resultant from diseases or trauma.134 To
assess the bioactivity of biomaterials, in vitro testing is usually carried out to confirm the
formation of HA layer on the material surfaces. Kokubo et al135 and Hench et al136
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introduced acellular solutions with ion concentrations nearly equal to those of human
blood plasma known as simulated body fluid (SBF), but they are richer in Cl− ion and
poorer in HCO3− (Table 1-1).
Table 1-1: Ionic compositions (in mM) of human blood plasma and SBF.137

Ion

Na+

K+ Mg2+ Ca2+

Human blood plasma 142.0 5.0
SBF

142.0 5.0

Cl-

HCO-3 HPO42- SO42-

1.5

2.5

103.0

27.0

1.0

0.5

1.5

2.5

147.8

4.2

1.0

0.5

Many researchers have used SBF to investigate the bioactivity of biomaterials.
Specimens are soaked in SBF at body temperature for different time-points, and the
material surfaces are investigated later. A material that shows apatite formation on its
surface in SBF in a short time, usually bonds to living bone.137
The mechanism of bioactivity is time-dependent as discussed in the literature. Several
stages are included in this mechanism: 25,138
i.

Rapid exchange of Na+ or K+ with H+ or H3O+ from the solution.

ii.

Loss of soluble silica in the form of Si(OH)4 to the solution, resulting from
breakage of the Si-O-Si bond and formation of Si-OH (silanols) at the material
solution interface. The SiO2-rich layer is condensed and repolymerized on the
surface depleted in alkalis and alkaline cations.
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iii.

Ca2+ and PO43− groups are migrated to the material surface through the SiO2-rich
layer to form a CaO-P2O5-rich film on top of the SiO2-rich layer.

iv.

Amorphous CaO-P2O5-rich film grows by incorporation of soluble calcium and
phosphates from SBF.

v.

Finally, Amorphous hydroxycarbonate apatite (HCA) film crystallizes by
incorporation of OH−, CO2−, or F− anions from the solution.

The last two stages are critical for controlling the biological activity of different
biomaterials. If these stages are extremely slow, the material is considered as nonbioactive because there will be little or no bonds formed on the surface of bone. On the
contrary, in a case of a very fast reaction, a resorption will be observed and the material is
considered as biodegradable and resorbable. With a bioactive material that exhibits bonebond formation, these stages must closely match the time of bone biomineralization.25
The process of apatite formation can be characterized by different tests such as X-ray
diffraction (XRD), Fourier transform infrared reflection spectroscopy (FTIR), energy
dispersive X-ray spectroscopy (EDX) and scanning electron microscopy (SEM). Studies
showed that apatite started to nucleate on the silica gel layer, and then they grew to make
a spherulitic form by consuming the calcium and phosphate ions from the surrounding
fluid. Each spherulitic structure consisted of plenty of flakes of HCA. The Ca/P ratio of
the apatite was estimated around 1.5-1.6. Thus, the apatite formed was able to induce
secondary nucleation of the apatite.139
The commercially available dental implants (titanium and zirconia) are bioinert. Several
bioactive materials such as BIOGLASS® 140 HA and wollastonite130,141 have been used as
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coatings on the implant substrate, to modify their surfaces and make them bioactive.
Various techniques have been used to prepare the bioactive coatings like plasmaspraying,130 micro-arc oxidation,142 electro-hydrodynamics spray deposition, sputter
technique,143 sol-gel and vacuum deposition.14 There are some limitations to bioactive
coatings. They could fail during cooling from the fabrication temperature, under service
stresses, or due to lack of adhesion between the coating and the substrate.144 Some coating
materials such as HA exhibited microstructural changes that lead to a very slow
osseointegration rate and could jeopardize the long-term stability of an implant.141
The development of bioactive GCs for dental implant applications with suitable
mechanical properties is considered as a substantial challenge for researchers and yet
remarkable progress in the dental implantology field is occurring. The motivation of this
research is to synthesize bioactive, machinable and biocompatible with suitable
mechanical properties as an alternative to metallic non-bioactive dental implant material.

1.6 THESIS HYPOTHESES AND OBJECTIVES
The overlying hypothesis of this study is that GCs can be synthesized with properties
suitable for use in non-metallic, one-piece dental implant applications. In particular, our
aim was to produce bioactive, biocompatible and machinable GCs that exhibited
appropriate mechanical, physical, optical and chemical properties to overcome the
limitations associated with current commercial dental implant systems (titanium or
zirconia). We also hypothesized that one could synthesize transparent precursor glass
with wet chemistry methods and then sintering the glass powder to produce GC. A further
hypothesis was that modification of glass composition and heat treatment schedules
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would improve the mechanical, physical and chemical properties of resultant GCs.
Overall, we proposed that multiphase GCs constituted of miserite or wollastonite as the
main crystalline phases are suitable materials for non-metallic, one-piece dental implant
applications owing to their superior mechanical properties, excellent chemical durability,
machinability, osteogenic potential and biocompatibility.
In order to test these hypotheses, the specific objectives of the research were:
1. To fabricate dental transparent glasses in different systems by wet chemistry.
2. To study the crystallization kinetics of the glasses.
3. To synthesize a miserite GC by cold pressing and sintering, and to characterize its
mechanical, physical and biological properties.
4. To investigate the effect of modifying heat treatment schedules on the mechanical
properties of miserite GC.
5. To synthesize a wollastonite GC by cold pressing and sintering, and to characterize its
mechanical, physical, chemical and biological properties.
6. To investigate the effect of modifying the parent glass chemical composition on the
mechanical and chemical properties of wollastonite GC.

1.7 THESIS ORGANIZATION
The work presented in this thesis focuses on synthesis and characterization of novel GCs
for dental implant applications. Chapter 1 presented the rationale, background and
pertinent literature review. Chapter 2 (Saadaldin et al145) describes the synthesis of base
glass, characterization of the crystallization kinetics of the glass, and synthesis of four
GCs from the glass powder using different heat treatment schedules. Characterization of
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the crystalline phases, microstructure, mechanical properties and machinability of the
GCs are presented. Finally, testing bioactivity in SBF and biocompatibility (osteoblast
morphology, attachment and proliferation) of the miserite GC that exhibited the best
mechanical properties are presented. Chapter 3 (Saadaldin et al146) describes the
synthesis of precursor glasses, characterization of their crystallization kinetics, and
synthesis of three wollastonite GCs from glass powders that had variable weight
percentages of their chemical constituents. The mechanical properties, machinability and
chemical durability of the wollastonite GCs are presented. Fracture toughness values of
the wollastonite GCs before and after chemical degradation testing is reported. The GC
that showed the best mechanical properties and excellent chemical durability was selected
for the following study. Chapter 4 (Saadaldin et al147) describes evaluation of the
bioactivity in SBF and biocompatibility (including osteoblast attachment, focal adhesion
formation, proliferation and ALP activity) of the wollastonite GC, which was synthesized
as described in Chapter 3. Chapter 5 includes the general discussion, overall conclusions,
significances, limitations of the study and a brief description of potential areas for future
studies.

42

1.8 REFERENCES
1.

O'Brien WJ. Dental Materials and Their Selection. 4th ed. Hanover Park, IL:
Quintessence Pub. Co.; 2008.

2.

Ferracane JL. Materials in Dentistry: Principles and Applications. 2nd ed.
Philadelphia: Lippincott Williams & Wilkins; 2001.

3.

Cooper LF. A Role for Surface Topography in Creating and Maintaining Bone at
Titanium Endosseous Implants. J Prosthet Dent. 2000 11; 84(5):522-34.

4.

Garg AK. Bone Biology, Harvesting, Grafting for Dental Implants: Rationale and
Clinical Applications. Chicago: Quintessence Pub. Co.; 2004.

5.

Ellingsen JE, Thomsen P, Lyngstadaas P. Advances in Dental Implant Materials
and Tissue Regeneration. Periodontol 2000. 2006; 41(1):136-56.

6.

Babbush CA. Dental implants: The Art and Science. 2nd ed. Maryland Heights, Mo.:
Saunders/Elsevier; 2011.

7.

Anusavice KJ, Phillips RW, Shen C, Rawls HR. Phillips' Science of Dental
Materials. 12th ed. St. Louis, Mo.: Elsevier/Saunders; 2013.

8.

Ratner BD. Biomaterials Science: An Introduction to Materials in Medicine. San
Diego: Academic Press; 1996.

9.

Parker C. The Growth of Implant Dentistry. Dentist Magazine. 2012; 28(9).

10.

Natali AN. Dental Biomechanics. London; New York: Taylor & Francis; 2003.

11.

Leyens C, Peters M. Titanium and Titanium Alloys; Fundamentals and
Applications. Weinheim: Wiley-VCH; 2003.

43

12.

Wang RR, Li Y. In Vitro Evaluation of Biocompatibility of Experimental Titanium
Alloys for Dental Restorations. J Prosthet Dent. 1998 10; 80(4):495-500.

13.

Misch CE. Contemporary Implant Dentistry. 3rd ed. St. Louis: Mosby Elsevier;
2008.

14.

Gross KA, Berndt CC. Biomedical Application of Apatites. Rev Mineral Geochem.
2002; 48(1):631-72.

15.

Jayaswal GP, Dange SP, Khalikar AN. Bioceramic in Dental Implants: A Review. J
Ind Pros Society. 2010; 10(1):8-12.

16.

Rosenstiel SF, Land MF, Fujimoto J. Contemporary Fixed Prosthodontics. 4th ed.
St. Louis, Mo.: Mosby Elsevier; 2006.

17.

Powers JM, Wataha JC. Dental Materials: Properties and Manipulation. 10th ed. St.
Louis, Mo.: Mosby/Elsevier; 2013.

18.

Mine Y, Makihira S, Nikawa H, Murata H, Hosokawa R, Hiyama A, et al. Impact
of Titanium Ions on Osteoblast, Osteoclast and Gingival Epithelial-like Cells. J
Prosthodont Res. 2010; 54(1):1-6.

19.

Sicilia A, Cuesta S, Coma G, Arregui I, Guisasola C, Ruiz E, et al. Titanium
Allergy in Dental Implant Patients: A Clinical Study on 1500 Consecutive Patients.
Clin Oral Implants Res. 2008; 19(8):823-35.

20.

Siddiqi A, Payne AGT, De Silva RK, Duncan WJ. Titanium allergy: Could it Affect
Dental Implant Integration? Clin Oral Implant Res. 2011; 22(7):673-80.

44

21.

Olmedo DG, Paparella ML, Brandizzi D, Cabrini RL. Reactive Lesions of PeriImplant Mucosa Associated with Titanium Dental Implants: A report of 2 Cases. Int
J Oral Maxillofac Surg. 2010; 39(5):503-7.

22.

Makihira S, Mine Y, Nikawa H, Shuto T, Iwata S, Hosokawa R, et al. Titanium Ion
Induces Necrosis and Sensitivity to Lipopolysaccharide in Gingival Epithelial-Like
Cells. Toxicol In Vitro. 2010; 24(7):1905-10.

23.

Egusa H, Ko N, Shimazu T, Yatani H. Suspected Association of An Allergic
Reaction With Titanium Dental Implants: A Clinical Report. J Prosthet Dent. 2008;
100(5):344-7.

24.

Wenz HJ, Bartsch J, Wolfart S, Kern M. Osseoitegration and Clinical Success of
Zirconia Dental Implants: A Systematic Review. Int J Prosthodont. 2008; 21(1):2736.

25.

Hench L. Bioceramics-From Concept to Clinic. J Am Ceram Soc. 1991;74(7):1487510.

26.

Sykaras N, Iacopino AM, Marker VA, Triplett RG, Woody RD. Implant Materials,
Designs, and Surface Topographies: Their Effect on Osseointegration. A Literature
Review. Int J Oral Maxillofac Implants. 2000;15(5):675-90.

27.

Volpato CÂM, Garbelotto LGDA, Fredel M.C.and Bondioli F. Application of
Zirconia in Dentistry: Biological, Mechanical and Optical Considerations. In:
Sikalidis C, editor. Advances in Ceramics - Electric and Magnetic Ceramics,
Bioceramics, Ceramics and Environment. 1st ed. Croatia: InTech; 2011. p. 397-420.

45

28.

Kohal R, Klaus G. A Zirconia Implant-Crown System: A Case Report. Int J
Periodontics Restorative Dent. 2004;24(2):147-53.

29.

Bächle M, Butz F, Hübner U, Bakalinis E, Kohal RJ. Behavior of CAL72
Osteoblast-Like Cells Cultured on Zirconia Ceramics with Different Surface
topographies. Clin Oral Implants Res. 2007; 18(1):53-9.

30.

Kohal R-, Papavasiliou G, Kamposiora P, Tripodakis A, Strub JR. ThreeDimensional Computerized Stress Analysis of Commercially Pure Titanium and
Yttrium-Partially Stabilized Zirconia Implants. Int J Prosthodont. 2002; 15(2):18994.

31.

Silva NRFA, Coelho PG, Fernandes CAO, Navarro JM, Dias RA, Thompson VP.
Reliability of One-Piece Ceramic Implant. J Biomed Mater Res B Appl Biomater.
2009; 88(2):419-26.

32.

Aydın C, Yılmaz H, Bankoğlu M. A Single-Tooth, Two-Piece Zirconia Implant
Located in the Anterior Maxilla: A Clinical Report. J Prosthet Dent. 2013;
109(2):70-4.

33.

Manicone PF, Rossi Iommetti P, Raffaelli L. An Overview of Zirconia Ceramics:
Basic Properties and Clinical Applications. J Dent. 2007; 35(11):819-26.

34.

Andreiotelli M, Kohal RJ. Fracture Strength of Zirconia Implants after Artificial
Aging. Clin Implant Dent Relat Res. 2009; 11(2):158-66.

35.

Knahr K. Total Hip Arthroplasty. Berlin; New York: Springer; 2013.

36.

Höland W, Beall GH. Glass-Ceramic Technology. Westerville, USA: American
Ceramic Society; 2002.

46

37.

Hisbergues M, Vendeville S, Vendeville P. Zirconia: Established Facts and
Perspectives for a Biomaterial in Dental Implantology. J Biomed Mater Res. 2009;
88B(2):519-29.

38.

Cavalcanti AN, Foxton RM, Watson TF, Oliveira MT, Giannini M, Marchi GM. YTZP ceramics: Key Concepts for Clinical Application. Operative Dentistry. 2009;
34(3):344-51.

39.

Van Noort R. Introduction to Dental Materials. 4th ed. Edinburgh; New York:
Mosby/Elsevier; 2013.

40.

Piconi C, Maccauro G. Zirconia as a Ceramic Biomaterial. Biomaterials. 1999;
20(1):1-25.

41.

Flinn BD, deGroot DA, Mancl LA, Raigrodski AJ. Accelerated Aging
Characteristics of Three Yttria-Stabilized Tetragonal Zirconia Polycrystalline
Dental Materials. J Prosthet Dent. 2012 10; 108(4):223-30.

42.

Tinschert J, Natt G, Mohrbotter N, Spiekermann H, Schulze KA. Lifetime of
Alumina and Zirconia Ceramics Used for Crown and Bridge Restorations. J
Biomed Mater Res. 2007; 80B (2):317-21.

43.

Vagkopoulou T, Koutayas S, Koidis P, Strub J. Zirconia in Dentistry: Part 1.
Discovering the Nature of An Upcoming Bioceramic. Eur J Esthet Dent. 2009;
4(2):130-51.

44.

Cales B. Zirconia as a Sliding Material-Histologic, Laboratory, and Clinical data.
Clin Orthop Relat Res. 2000; 13(379):94-112.

47

45.

Özkurt Z, Kazazoglu E. Zirconia Dental Implants: A Literature Review. J Oral
Implant. 2011;37(3):367-76.

46.

Brunski JB. Biomechanical Factors Affecting the Bone-Dental Implant Interface.
Clin Mater. 1992; 10(3):153-201.

47.

Weiss C, Weiss A. Principles and Practice of Implant Dentistry. St. Louis, Mo.:
Mosby; 2001.

48.

Ratner B. Replacing and Renewing: Synthetic Materials, Biomimetic, and Tissue
Engineering in Implant Dentistry. J Dent Edu. 2001; 65(12):1340-7.

49.

Clarke B. Normal Bone Anatomy and Physiology. Clin J Am Soc Nephrol. 2008;
3(S3):131-9.

50.

Zonfrillo G, Pratesi F. Mechanical Strength of Dental Implants. J of Appl Biomater.
2008 05; 6(2):110-8.

51.

Zhang Y, Wang J, Wang P, Fan X, Li X, Fu J, et al. Low Elastic Modulus
Contributes to the Osteointegration of Titanium Alloy Plug. J Biomed Mater Res.
2013; 101B (4):584-90.

52.

Andreiotelli M, Wenz HJ, Kohal R. Are Ceramic Implants a Viable Alternative to
Titanium Implants? A Systematic Literature Review. Clin Oral Implants Res. 2009;
20(S4):32-47.

53.

Park JB, Lakes RS. Biomaterials: An Introduction. 3rd ed. New York; London:
Springer; 2007.

48

54.

Lee W, Koak J, Lim YJ, Kim S, Kwon H, Kim M. Stress Shielding and Fatigue
Limits of Poly-Ether-Ether-Ketone Dental Implants. J Biomed Mater Res. 2012;
100B (4):1044-52.

55.

Pattanayak D, Rao B, Mohan T. Calcium Phosphate Bioceramics and Bioceramic
Composites. J Sol-Gel Sci Techn. 2011; 59(3):432-47.

56.

Koleganova VA, Bernier SM, Dixon SJ, Rizkalla AS. Bioactive Glass/Polymer
Composite Materials with Mechanical Properties Matching those of Cortical Bone.
J Biomed Mater Res. 2006; 77A (3):572-9.

57.

Li Z, Ghosh A, Kobayashi AS, Bradt RC. Indentation Fracture Toughness of
Sintered Silicon Carbide in the Palmqvist Crack Regime. J Am Ceram Soc. 1989;
72(6):904-11.

58.

Chan RN, Stoner BR, Thompson JY, Scattergood RO, Piascik JR. Fracture
Toughness Improvements of Dental Ceramic Through Use of Yttria-Stabilized
Zirconia (YSZ) Thin-Film Coatings. Dent Mater. 2013 8; 29(8):881-7.

59.

Smith WF, Hashemi J. Foundations of Materials Science and Engineering. 5th ed.
Boston: McGraw-Hill Higher Education; 2010.

60.

Ponton CB, Rawlings RD. Vickers Indentation Fracture Toughness Test Part 1
Review of Literature and Formulation of Standardized Indentation Toughness
Equations. Mat Sci Tech. 1989; 5(9):865-72.

61.

Lankford J. Indentation Microfracture in the Palmqvist Crack Regime: Implications
for Fracture Toughness Evaluation by the Indentation Method. J Mater Sci Mater
lett. 1982; 1(11):493-5.

49

62.

Bonsor SJ, Pearson GJ. A Clinical Guide to Applied Dental Materials. Amsterdam;
Boston: Elsevier/Churchill Livingstone; 2013.

63.

Niinomi M. Fatigue Characteristics of Metallic Biomaterials. Int J Fatigue.
2007;29(6):992-1000.

64.

Niinomi M. Mechanical Properties of Biomedical Titanium Alloys. Mat Sci Eng A.
1998;243(1-2):231-6.

65.

Kim MG. Fatigue Properties on the Failure Mode of a Dental Implant in a
Simulated Body Environment. Met Mater Int. 2011;17(5):705-11.

66.

Studart AR, Filser F, Kocher P, Gauckler LJ. Fatigue of Zirconia Under Cyclic
Loading in Water and its Implications for the Design of Dental Bridges. Dent
Mater. 2007; 23(1):106-14.

67.

Varshneya AK. Fundamentals of Inorganic Glasses. London: Academic Press
Limited; 1994.

68.

Höland W, Rheinberger V, Apel E, Hoen C, Höland M, Dommann A, et al. Clinical
Applications of Glass-Ceramics in Dentistry. J Mater Sci Mater Med. 2006;
17(11):1037-42.

69.

Grossman DG. Machinable Glass-Ceramics Based on Tetrasilicic Mica. J Am
Ceram Soc. 1972; 55(9):446-9.

70.

Wang M. Biomaterials and Tissue Engineering. In: Shi D, editor. Bioactive
Materials and Processing. Berlin; New York: Springer; 2004. p. 1-72.

50

71.

Neo M, Kotani S, Nakamura T, Yamamuro T, Ohtsuki C, Kokubo T, et al. A
Comparative Study of Ultrastructures of the Interfaces between Four Kinds of
Surface-Active Ceramic and Bone. J Biomed Mater Res. 1992; 26(11):1419-32.

72.

Ohtsuki C, Kushitani H, Kokubo T, Kotani S, Yamamuro T. Apatite Formation on
the Surface of Ceravital-Type Glass-Ceramic in the Body. J Biomed Mater Res.
1991; 25(11):1363-70.

73.

Denry I, Holloway JA. Ceramics for Dental Applications: A Review. Materials
(1996-1944). 2010; 3(1):351-68.

74.

Höland W. Biocompatible and Bioactive Glass-Ceramics — State of the Art and
New directions. J Non Cryst Solids. 1997; 219(0):192-7.

75.

Höland W, Schweiger M, Rheinberger VM, Kappert H. Bioceramics and Their
Application for Dental Restoration. Adv Appl Ceram. 2009; 108(6):373-80.

76.

Höland W, Schweiger M, Watzke R, Peschke A, Kappert H. Ceramics as
Biomaterials for Dental Restoration. Expert Rev Med Devices. 2008; 5(6):729-45.

77.

Kelly JR, Benetti P. Ceramic Materials in Dentistry: Historical Evolution and
Current Practice. Aust Dent J. 2011; 56(1):84-96.

78.

Malament KA, Socransky SS. Survival of Dicor Glass-Ceramic Dental Restorations
Over 20 Years: Part IV. The Effects of Combinations of Variables. Int J
Prosthodont. 2010; 23(2):134-40.

79.

Rizkalla AS, Jones DW. Mechanical Properties of Commercial High Strength
Ceramic Core Materials. Dent Mater. 2004;20(2):207-12.

51

80.

Qin F, Zheng S, Luo Z, Li Y, Guo L, Zhao Y, et al. Evaluation of Machinability
and Flexural Strength of a Novel Dental Machinable Glass-Ceramic. J Dent. 2009;
37(10):776-80.

81.

Koutayas SO, Kern M. All-ceramic Posts and Cores: The State of the Art.
Quintessence Int. 1999; 30(6):383-92.

82.

Sorensen J.A., Mito W.T. Rationale and Clinical Technique for Esthetic restoration
of Endodontically Treated Teeth with the Cosmopost and IPS Empress Post
System. Quintessence Dent Technol. 1998; 12(21):80-91.

83.

Holand W, Schweiger M, Frank M, Rheinberger V. A Comparison of the
Microstructure and Properties of the IPS Empress®2 and the IFS Empress®GlassCeramics. J Biomed Mater Res. 2000; 53(4):297-303.

84.

Chen X, Chadwick TC, Wilson RM, Hill RG, Cattell MJ. Crystallization and
Flexural Strength Optimization of Fine-Grained Leucite Glass-Ceramics for
Dentistry. Dent Mater. 2011; 27(11):1153-61.

85.

Heintze SD, Rousson V. Fracture Rates of IPS Empress All-Ceramic Crowns.
A Systematic Review. Int J Prosthodont. 2010; 23(2):129-33.

86.

Teicholz E. CAD-CAM handbook. New York; Montreal: McGraw-Hill; 1985.

87.

Van Noort R. The Future of Dental Devices is Digital. Dent Mater. 2012; 28(1):312.

88.

CAD/CAM in Dentistry. Oral Health. 1997; 87(3):17-20.

52

89.

Mormann WH, Bindl A. The cerec 3 - A Quantum Leap for Computer-Aided
Restorations: Initial Clinical Results. Quintessence Int. 2000; 31(10):699-712.

90.

Conrad HJ, Seong W, Pesun IJ. Current Ceramic Materials and Systems with
Clinical Recommendations: A Systematic Review. J Prosthet Dent. 2007 11;
98(5):389-404.

91.

Kern M, Sasse M, Wolfart S. Ten-year Outcome of Three-Unit Fixed Dental
Prostheses Made from Monolithic Lithium Disilicate Ceramic. JADA. 2012;
143(3):234-40.

92.

Höland W, Rheinberger V, Apel E, Ritzberger C, Rothbrust F, Kappert H, et al.
Future Perspectives of Biomaterials for Dental Restoration. J Eur Cera Soc. 2009;
29(7):1291-7.

93.

Wolfart S, Eschbach S, Scherrer S, Kern M. Clinical Outcome of Three-Unit
Lithium-Disilicate Glass–Ceramic Fixed Dental Prostheses: Up to 8 Years Results.
Dent Mater. 2009; 25(9):63-71.

94.

Ferguson DB. Physiology for Dental Students. London; Boston: Wright; 1988.

95.

Bueno EM, Glowacki J. Biologic Foundations for Skeletal Tissue Engineering.
1537 Fourth Street, San Rafael, CA; 2011.

96.

Fanghänel J, Gedrange T, Proff P. Bone Quality, Quantity and Metabolism in
Terms of Dental Implantation. Biomed Tech (Berl). 2008; 53(5):215-19.

97.

Augat P, Schorlemmer S. The Role of Cortical Bone and its Microstructure in Bone
Strength. Age Ageing. 2006; 35:27-31.

53

98.

Gelse K, Pöschl E, Aigner T. Collagens-Structure, Function, and Biosynthesis. Adv
Drug Deliv Rev. 2003; 55(12):1531-46.

99.

Frost H. Wolff's Law and Bone's Structural Adaptations to Mechanical Usage: An
Overview for Clinicians. Angle Orthod. 1994; 64(3):175-88.

100. Horner KA, Behrents RG, Kim KB, Buschang PH. Cortical Bone and Ridge
Thickness of Hyperdivergent and Hypodivergent Adults. Am J Orthod Dentofacial
Orthop. 2012 8; 142(2):170-8.
101. Tripuwabhrut P, Mustafa M, Gjerde CG, Brudvik P, Mustafa K. Effect of
Compressive Force on Human Osteoblast-Like Cells and Bone Remodeling: An In
Vitro Study. Arch Oral Biol. 2013; 58(7):826-36.
102. Jenkins GW, Kemnitz CP, Tortora GJ. Anatomy and Physiology: From Science to
Life. Hobooken, N.J.: Wiley; 2007.
103. Thomas GP, Baker SUK, Eisman JA, Gardiner EM. Changing RANKL/OPG
mRNA Expression in Differentiating Murine Primary Osteoblasts. J Endocrinol.
2001; 170(2):451-60.
104. Bonewald LF. The Amazing Osteocyte. J Bone Miner Res. 2011; 26(2):229-38.
105. Kogianni G, Noble BS. The Biology of Osteocytes. Curr Osteoporos Rep. 2007;
5(2):81-6.
106. O'Brien

CA,

Nakashima

T,

Takayanagi

H.

Osteocyte

Control

of

Osteoclastogenesis. Bone. 2013; 54(2):258-63.
107. Suda T, Takahashi N, Martin TJ. Modulation of Osteoclast Differentiation. Endocr
Rev. 1992; 13(1):66-80.

54

108. Vaananen HK, Zhao H, Mulari M, Halleen JM. The Cell Biology of Osteoclast
Function. J Cell Sci. 2000; 113(3):377-81.
109. Everts V, Delaissé JM, Korper W, Jansen DC, TigchelaarGutter W, Saftig P, et al.
Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone
Formation. J Bone Miner Res. 2002;17(1):77-90.
110. Rosa V, Della Bona A, Cavalcanti BN, Nör JE. Tissue Engineering: From Research
to Dental Clinics. Dent Mater. 2012; 28(4):341-8.
111. Pivodova V, Frankova J, Ulrichova J. Osteoblast and Gingival Fibroblast Markers
in Dental Implant Studies. Biomed Pap. 2011;155(2):109-16.
112. Leung KS, Fung KP, Sher AH, Li CK, Lee KM. Plasma Bone-Specific Alkaline
Phosphatase as an Indicator of Osteoblastic Activity. J Bone Joint Surg Br. 1993;
75(B):288-92.
113. Harris H. The Human Alkaline Phosphatases: What We Know and What We Don't
know. Clin Chim Acta. 1990; 186(2):133-50.
114. Pelham RJ, Wang Y. Cell Locomotion and Focal Adhesions Are Regulated by
Substrate Flexibility. Proc Nati Acad Sci USA. 1997; 94(25):13661-5.
115. Petit V, Thiery J. Focal adhesions: Structure and Dynamics. Biol Cell. 2000;
92(7):477-94.
116. Hobkirk JA, Watson RM, Searson LJJ. Introducing Dental Implants. Edinburgh;
New York: Churchill Livingstone; 2003.
117. Palmer R. Dental Implants: Introduction to Dental Implant. Br Dent J. 1999;
187(3):127-32.

55

118. Barbucci

R.

Integrated

Biomaterials

science.

New

York:

Kluwer

Academic/Plenum; 2002.
119. Vasconcellos LMR, Oliveira MV, Graça MLA, Vasconcellos LGO, Cairo CAA,
Carvalho YR. Design of Dental Implants, Influence on the Osteogenesis and
Fixation. J Mater Sci Mater Med. 2008; 19(8):2851-7.
120. Winter W, Klein D, Karl M. Micromotion of Dental Implants: Basic Mechanical
Considerations. J Med Eng. 2013; 2013:1-9.
121. Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium
implants: Requirements for Ensuring a Long-Lasting, Direct Bone-to-Implant
Anchorage in Man. Acta Orthopaedica. 1981; 52(2):155-70.
122. Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface Treatments of
Titanium Dental Implants for Rapid Osseointegration. Dent Mater. 2007;
23(7):844-54.
123. Li HF, Wang YB, Zheng YF, Lin JP. Osteoblast Response on Ti- and Zr-Based
Bulk Metallic Glass Surfaces After Sand Blasting Modification. J Biomed Mater
Res B Appl Biomater. 2012; 100 B (7):1721-8.
124. Att W, Takeuchi M, Suzuki T, Kubo K, Anpo M, Ogawa T. Enhanced Osteoblast
Function on Ultraviolet Light-Treated Zirconia. Biomaterials. 2009; 30(7):1273-80.
125. Conner KA, Sabatini R, Mealey BL, Takacs VJ, Mills MP, Cochran DL. Guided
Bone

Regeneration

around

Titanium

Plasma-Sprayed,

Acid-Etched,

and

Hydroxyapatite-Coated Implants in the Canine Model. J Periodontol. 2003;
74(5):658-68.

56

126. Li D, Ferguson SJ, Beutler T, Cochran DL, Sittig C, Hirt HP, et al. Biomechanical
Comparison of the Sandblasted and Acid-Etched and the Machined and Acidetched Titanium Surface for Dental Implants. J Biomed Mater Res. 2002;
60(2):325-32.
127. Wataha, J.C. Materials for Endosseous Dental Implants. J Oral Rehabil. 1996;
23(2):79-90.
128. Palmquist A, Omar OM, Esposito M, Lausmaa J, Thomsen P. Titanium Oral
implants: Surface Characteristics, Interface Biology and Clinical Outcome. J R Soc
Interface. 2010; 7(s):S515-27.
129. Chen C, Huang T, Kao C, Ding S. Characterization of Functionally Graded
Hydroxyapatite/Titanium Composite Coatings Plasma-sprayed on Ti Alloys. J
Biomed Mater Res. 2006; 78B (1):146-52.
130. Cao H, Liu X. Plasma-Sprayed Ceramic Coatings for Osseointegration. Int J Appl
Ceram Technol. 2013; 10(1):1-10.
131. Ripamonti U, Roden LC, Renton LF. Osteoinductive Hydroxyapatite-Coated
Titanium Implants. Biomaterials. 2012; 33(15):3813-23.
132. Dalton JE, Cook SD. In Vivo Mechanical and Histological Characteristics of HACoated Implants Vary With Coating Vendor. J Biomed Mater Res. 1995; 29(2):23945.
133. Gottlander M, Johansson CB, Albrektsson T. Short and Long-Term Animal Studies
with a Plasma-Sprayed Calcium Phosphate-Coated Implant. Clin Oral Implants Res.
1997; 8(5):345-51.

57

134. Kokubo T. Bioactive Glass Ceramics: Properties and Applications. Biomaterials.
1991; 12(2):155-63.
135. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions Able to
Reproduce In Vivo Surface-Structure Changes in Bioactive Glass-Ceramic A-W. J
Biomed Mater Res. 1990; 24(6):721-34.
136. Filgueiras MR, La Torre G, Hench LL. Solution Effects on the Surface Reactions of
A Bioactive Glass. J Biomed Mater Res. 1993; 27(4):445-3.
137. Kokubo T, Takadama H. How Useful is SBF in Predicting In Vivo Bone
Bioactivity? Biomaterials. 2006; 27(15):2907-15.
138. Han YJ, Loo SCJ, Lee J, Ma J. Investigation of the Bioactivity and
Biocompatibility

of

Different

Glass

Interfaces

with

Hydroxyapatite,

Fluorohydroxyapatite and 58S Bioactive Glass. BioFactors. 2007; 30(4):205-16.
139. Li P, Ohtsuki C, Kokubo T, Nakanishi K, Soga N, Nakamura T, et al. Process of
Formation of Bone-Like Apatite Layer on Silica Gel. J Mater Sci: Mater-Med.
1993; 4(2):127-31.
140. Hench LL. The Story of Bioglass®. J Mater Sci Mater Med. 2006; 17(11):967-78.
141. Mistry S, Kundu D, Datta S, Basu D. Comparison of Bioactive Glass Coated and
Hydroxyapatite Coated Titanium Dental Implants in the Human Jaw Bone. Aust
Dent J. 2011; 56(1):68-75.
142. Song H, Kim J, Kook M, Moon W, Park Y. Fabrication of Hydroxyapatite and TiO2
Nanorods on Microarc-Oxidized Titanium Surface Using Hydrothermal Treatment.
Appl Surf Sci. 2010; 256(23):7056-61.

58

143. Best SM, Porter AE, Thian ES, Huang J. Bioceramics: Past, Present and For the
Future. J Euro Cora Soc. 2008; 28(7):1319-27.
144. Rawlings RD. Bioactive Glasses and Glass-Ceramics. Clinc Mat. 1993; 14(2):15579.
145. Saadaldin SA, Dixon SJ, Costa DO, Rizkalla AS. Synthesis of Bioactive and
Machinable Miserite Glass-Ceramics for Dental Implant Applications. Dent Mater.
2013; 29(6):645-55.
146. Saadaldin SA, Rizkalla AS. Synthesis and Characterization of Wollastonite glassCeramics for Dental Implant Applications. Dent Mater, 2013, Accepted for
publication, DEMA-D-00398.
147. Saadaldin SA, Dixon SJ, Rizkalla AS. Bioactivity and Biocompatibility of a
Novel Wollastonite Glass-Ceramic. Submitted for publication, 2013

59

CHAPTER 2
SYNTHESIS OF BIOACTIVE AND MACHINABLE MISERITE
GLASS-CERAMICS FOR DENTAL IMPLANT APPLICATIONS
This chapter describes a novel approach for the synthesis of miserite GC with
mechanical, physical and biological properties required for non-metallic dental implant
applications. The contents of this chapter have been reproduced (with modifications)
from: Saadaldin, SA; Dixon, SJ; Costa, DO and Rizkalla, AS. Synthesis of bioactive and
machinable miserite glass-ceramics for dental implants applications. Dental Materials.
2013 Jun; 29(6): 645-655. doi: 10.1016/j.dental.2013.03.013, with permission from
Elsevier (Appendix A).

2.1 INTRODUCTION
Dental implantology has become a predictable treatment for patients with missing teeth.
Titanium (Ti) is the material most widely used for dental implants due to its superior
mechanical properties, biocompatibility and resistance to corrosion. However, a long term
clinical study revealed biological and technical complications with Ti dental implants.1
Hypersensitivity and allergic reactions to Ti dental implants occur, although these
reactions are under-reported, and the etiological factors of implant failure are poorly
understood.2-4 In addition, the esthetic outcomes of Ti dental implants can be
compromised in cases of gingival tissue recession, especially when replacing anterior
teeth.5
Ceramics were introduced as potential materials for non-metallic dental implants. Among
a variety of choices, the material currently used is yttria-stabilized tetragonal zirconia (YTZP).6 Advantages of zirconia include tooth-like color, good mechanical properties,
biocompatibility, low affinity for plaque, and osseointegration comparable with Ti dental
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implants.5,7 However, zirconia undergoes accelerated aging under stress in the presence of
moisture, leading to surface deterioration, nucleation and propagation of microcracks that
can result in spontaneous catastrophic failure.8-10
Bioactivity is defined as the ability of biomaterials to promote the formation of a
crystalline HA layer from physiological fluid.11 In implantology, there is considerable
interest in bioactive materials to establish strong chemical bonding between the implant
and bone, as well as to accelerate implant anchorage by inducing an HA layer on the
implant surface.12,13 Ti and zirconia are considered bioinert; therefore, to improve their
osseointegration, different bioactive coatings such as plasma-sprayed HA have been
developed.5,14 However, such coatings do not degrade uniformly, giving rise to weak
points at the bone-coating-implant interfaces.11
GCs are produced by controlled nucleation and crystallization of glasses, and their
properties can be tailored for specific applications.15 Glass crystallization can be
determined by differential thermal analysis (DTA), which is thermoanalytic technique
that is universally accepted as a rapid and convenient mean for determining the nucleation
and crystallization temperature of glasses.16 Experimental glass and an inert reference (αAl2O3) are made to undergo identical thermal cycles, the temperature differences between
sample and the reference are used to get DTA curve that provide data on glass transition,
crystallization and melting.17 The appearance of endothermic and exothermic peaks in the
DTA curve corresponds to nucleation and crystallization temperature, respectively.18
There is great interest in GCs that possess appropriate physical, mechanical and
biological properties for biomedical applications. These properties can be improved and
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modified by varying the base glass composition or heat treatment conditions.15 Currently,
several bioactive GCs are used for orthopaedic applications, including vertebral
prostheses, middle ear devices and bone defect fillers.15 Miserite is a triclinic potassium
calcium silicate mineral [KCa5(Si2O7)(Si6O15)(OH)F], which has a lath or rod-like crystal
shape.19 Miserite was introduced in 1999 as the predominant crystal phase in multi-phase
GCs that showed high bending strength (175 MPa) and high fracture toughness
(>3.5 MPa·m0.5).20 It is anticipated that miserite GC is biocompatible and bioactive;
however, it has not been evaluated previously as a material for dental implant
applications.20
Machinable biomaterials allow dentists to design and fabricate customized dental
restorations with a high level of accuracy and precision through CAD-CAM technology.21
Introducing CAD-CAM technology in dental implantology offers dental clinicians a
variety of treatment plans, with customized implants for each individual patient. The
objective of this study was to synthesize and characterize bioactive and machinable
miserite GCs, with physical, mechanical and biological properties appropriate for dental
implant materials.

2.2 MATERIALS AND METHODS:
2.2.1 Glass Synthesis
Preliminary unpublished work conducted in our laboratory involved the synthesis of a
range of multicomponent glass compositions in the system (SiO2-Al2O3-CaO-CaF2-K2OB2O3-La2O3) by wet chemical synthesis using sol-gel chemistry followed by spraydrying, calcinations and melting. The glass composition (wt %) that was selected for the
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present study was 57.8 SiO2, 0.5 Al2O3, 18.4 CaO, 12.6 CaF2, 6.8 K2O, 1.0 B2O3 and
2.9 La2O3. The rationale for using this composition was based on getting transparent
glass, lowering the glass melting in addition to optimizing its mechanical properties. We
made sure that the reagents used were of high purity and soluble in water to insure the
homogeneity of the final product. The glass was synthesized through the following four
steps:
1) Hydrolysis and polycondensation of metal alkoxides by mixing appropriate amounts of
Si(C2H5O)4, Al(NO3)39H2O, Ca(NO3)24H2O, CaF2, KNO3, H3BO3 and La(NO3)36H2O in
aqueous solution using excess deionized water.
2) Spray-drying with feed flow rate of 10 ml/min, inlet air temperature of 160 °C and
outlet air temperature of 80 °C using a 190 mini spray-dryer (BÜCHI, Switzerland),
yielding a spray-dried powder.
3) Calcination of the powder by heating incrementally at 200 °C, 500 °C and 700 °C for
2 h each in a Ney 650 vacuum oven (Ney-Barkmeyer, USA).
4) Melting of the calcined powder in an uncovered platinum crucible at 1150 °C for 3 h
and 1250 °C for 1 h in a high temperature furnace (Thermolyne Corporation, USA),
followed by quenching in iced water to obtain transparent glass frits.

2.2.2 Crystallization Kinetics
Transition and crystallization temperatures of experimental glasses were determined by
DTA using a SDT Q600 V20.5 Build 15 system (TA Instruments, USA) under air
atmosphere at five different heating rates (10-50 °C/min), starting from room temperature
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up to 1200 °C. The average sample weight was 20 mg and an equivalent weight of αAl2O3 was used as a reference. The activation energy (∆E) was calculated from the plot of
ln ((Tp)2/Ø) vs 1000/Tp using the Kissinger equation,17 where Tp is the exothermic peak as
determined from the DTA spectra and Ø is the heating rate (°C/s). The Avrami exponent
(nA) was determined from the DTA exothermic peak using the Augis-Bennett equation16

Avrami Exponent (nA)=

(2.5 ΔT ) ……………………………………………(Eq 2-1)

(RT

2
P

ΔE

)

where ∆T is the full width at the half maximum of the exothermic peak determined at
heating rate 20 °C/min, R is the universal gas constant (8.314 J/mol·K) and ∆E (kJ/mol) is
the activation energy of crystallization.

2.2.3 Preparation of Glass-Ceramics
Glass powders were ground using a planetary ball mill, Pulverisette 7 (Laval Lab, USA)
and mixed with 4% polyethylene glycol as a binder. Cylindrical ingots (6 mm X 10 mm)
and disk specimens (12 mm X 1 mm) of the glass powder were produced by cold pressing
by means of a Carver laboratory cold press (Carver, USA) in stainless steel dies at
40 MPa.
To study the effect of heat treatment on mechanical properties and crystallization of GCs,
four different heating schedules were performed to produce four different GCs from the
precursor glass (GC1, GC2, Gc3 and GC4). Pressed glass specimens were heated to
600 °C (glass transition temperature Tg) for 1 h, after which the temperature was
subsequently increased to the crystallization temperatures determined from the DTA
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exothermic peaks. The firing shrinkage of the resultant GCs was calculated from the
values of the specimen diameters before and after sintering.

2.2.4 X-Ray Diffraction (XRD)
Crystalline phases within the GCs were studied by XRD using a Rotaflex RTP 300 RC
(Rigaku Corp., Japan) operating on CoKα radiation at 45 kV and 160 mA. Spectra were
collected in the 2θ range between 2 and 82°, with 0.05° step and 10°/min scan speed. 2θ
for equivalent CuKα radiation was calculated using Bragg’s Law.22

2.2.5 Microstructure
The fracture surfaces of the GCs were examined using LEO 1540XB FIB/SEM (Zeiss,
Germany) equipped with an energy dispersive X-ray spectroscopy (EDX) system. Prior to
SEM analysis, samples were mounted on aluminum stubs and then coated with 3 nm
osmium metal (Filgen OPC 80T).

2.2.6 Dynamic Young’s Modulus of the Glass and GCs
Poisson’s ratio and dynamic Young’s moduli of the glass and GCs were measured using a
pulsed ultrasonic method. Lithium niobate crystals were used for transmitting and
receiving signals, which were generated at 10 MHz resonant frequencies. The elastic
parameters were calculated using the following equations.23
2

0.5(VL VS ) − 1
Poisson’s ratio (υ)= `
…………………………………………...(Eq1-2)
(VL VS )2 − 1

Young’s Modulus (E) =

(1 + υ )(1 − 2υ ) ρV 2 ……….…………………………….(Eq1-3)
L
(1 − υ )
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where VL and VS are the longitudinal and shear wave velocities, respectively, which were
calculated from the thickness of each specimen and the travelling time of the waves
across the specimen as determined using a V-66S oscilloscope at 60 MHz (Hitachi,
Japan). The density of each specimen (ρ) was determined using the Archimedes method
in distilled water at room temperature.

2.2.7 True Hardness
The true hardness (Ho) of the glass and GCs specimens was determined using a Buehler
Micromet 5114 Knoop micro hardness indenter (Buehler, USA). Glass and GCs
specimens were embedded in resin and polished. A series of Knoop indentations were
performed on each specimen at six different loads (0.49-9.9 N). The average diagonal
lengths of the Knoop indentations were measured using Buehler OmniMet MHT 7.2
Rev.2 optical microscope equipped with a digital camera and computer software
(Buehler, USA). Indentation lengths were plotted vs the square root of the different load
values, and Ho was calculated from the slope of the linear regression line (S) using the
following equation.24
True hardness (Ho) = 14229 S

2

………………………………………………………………………..…… (Eq2-4)

2.2.8 Fracture Toughness
The facture toughness (KIC) of the glass and GCs were assessed using Micromet 5114
Vickers micro hardness indenter (Buehler, USA). The diagonals of the Vickers
indentation and the crack lengths were measured to calculate the KIC using the Lankford
equation.25
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(

)

Fracture Toughness (KIC) = 0.0782 H o (a )0.5 (E H o )0.4 (c a )−1.56 ………………(Eq2-5)
where Ho is the true hardness (GPa), a is half the diagonal of the Vickers indentation
(µm), E is the dynamic Young’s modulus (GPa), and c is the crack length from the corner
of the Vickers indentation (µm). The average KIC was calculated from 15 indentations
performed on each specimen at a load of 9.8 N.

2.2.9 Machinability
The machinability of the GCs was assessed qualitatively by drilling holes and preparing
the samples by cutting shoulder finish lines, bevels and grooves with different depths.
Quantitative evaluation of the machinability of the GCs was performed by calculating the
brittleness index, which is the ratio of hardness to fracture toughness.26
Brittle Index (BI) = H o K IC …………………………………………………..…(Eq2-6)

2.2.10 Bioactivity
The GC that exhibited the best mechanical properties was selected for bioactivity and cell
compatibility studies. The ability of GC4 to induce formation of an apatite surface layer
was evaluated by means of soaking in SBF in vitro.27 Specimens were immersed in SBF
at 37 °C for 1, 2 and 4 weeks. At predetermined times, specimens were thoroughly rinsed
and dried. The surface layer formed on each specimen was assessed using SEM, EDX and
XRD.
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2.2.11 Cell Number and Morphology
MC3T3-E1 Subclone 4 (ATCC/CRL-2593, USA) osteoblast-like cells are a clonal nontransformed cell line originally established from newborn mouse calvariae.28 These cells
exhibit properties of osteoblasts, including elevation of cyclic AMP in response to
parathyroid hormone, expression of transcripts for Runx2, bone sialoprotein and
osteocalcin, and formation of bone-like matrix in vitro and in vivo.29 GC4 discs were
compared to sandblasted and acid-etched titanium (STi) as a positive control. STi discs
were generously supplied by Institut Straumann AG. GC4 (12 mm X 1 mm) and STi
(15 mm X 1 mm) discs were cleaned and sterilized using an argon-based plasma cleaner
PDC-32G (Harrick plasma, USA), placed in 24-well plates, and seeded with 5,000 cells
per well. Culture medium consisted of α-minimum essential medium (α-MEM,
Invitrogen, CA) buffered with HCO3-, and supplemented with 10% heat-inactivated fetal
bovine serum (FBS) and 1% antibiotic solution (10,000 U/ml penicillin, 10,000 µg/ml
streptomycin, and 25 µg/ml amphotericin B). After 6, 24 and 72 h incubation at 37 °C in
a humidified atmosphere of 5% CO2 in air, cells were fixed with 4% paraformaldehyde.
After fixation, cells were stained for filamentous actin (F-actin) using rhodamine
phalloidin (1:100 in 3% BSA in PBS). Images were obtained using an Axiovert inverted
fluorescence microscope (Carl Zeiss, Germany). Samples were mounted on glass
coverslips using Vectashield (Vector Laboratories, CA) with 4', 6-diamidino-2phenylindole dihydrochloride (DAPI) for visualization of cell nuclei. The number of cells
present at 6, 24 and 72 h was calculated from 10 randomly selected fields from each
specimen.
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2.2.12 Cell Proliferation Assay
MC3T3-E1 cells were seeded at 5,000 cells per well on GC4 and STi discs and the
culture medium was refreshed every other day. At 1, 3, 5 and 7 days, culture medium was
removed and specimens with cells were frozen at -80 °C. MC3T3-E1 cell numbers were
determined using CyQuant® cell proliferation assay kit (Invitrogen, USA). All specimens
were thawed at room temperature, then 400 µL of the CyQuant® GR dye/cell lysis buffer
was added to each sample surface. A fluorescence microplate reader (Tecan Safire, USA)
was used to measure fluorescence intensity of the dye/buffer at emission of 520 nm and
excitation of 480 nm. Fluorescence intensity was converted to cell number using a
standard curve. Cell numbers were normalized to account for the difference in surface
area between the GC4 and STi specimens.

2.2.13 Statistical Analyses
Differences between two groups were evaluated by t tests. Differences among three or
more groups were evaluated by one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparisons test. Differences were accepted as statistically significant
at p<0.05; N indicates the number of independent experiments.

2.3 RESULTS
2.3.1 Differential Thermal Analysis (DTA) of Glass
The crystallization kinetics of the experimental glass that was synthesized by wet
chemical methods was determined by DTA. When the glass was heated, the DTA
spectrum displayed three important features (Figure 2-1A). The first shoulder
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endothermic peak corresponds to the glass transition temperature (Tg). The exothermic
peaks (Tp1 and Tp2) demonstrate the crystallization temperatures of the glass. The second
endothermic peak reveals the liquidus temperature (Te), which resulted from
decomposition and dissolution of the crystalline phases.
DTA was performed at five different heating rates (Table 2-1). Tg, Tp1, Tp2 and Te
increased as the heating rate was increased. The Avrami exponent (nA) at the
crystallization temperature was calculated from the full width at the half maximum of the
exothermic peak(s) at 20 °C/min (Figure 2-1B). The nA values for the two crystallization
temperatures are displayed in Table 2-2. The nA value for TP1 was 1.1 (consistent with
surface crystallization), whereas the nA value for Tp2 was 2.8 (consistent with bulk
crystallization).18 The activation energies of crystallization of the two exothermic peaks
(Table 2-2) were calculated from the slope of the regression lines (ln ((Tp) 2/Ø) vs.
1000/Tp) displayed in Figure 2-1C. Based on the DTA data, four heating schedules were
selected for crystallization of four different GCs (Table 2-3).

2.3.2 XRD Analysis of Glass and GCs
XRD spectrum of the as-quenched glass confirmed its amorphous nature as revealed by
the shallow hump at 2θ = 25°– 35° (Figure 2-2A). The glass specimens were sintered
using four heating schedules (Table 2-3), yielding GC1, GC2, GC3 and GC4. XRD of
GC1 revealed crystalline phases consisting predominately of calcium fluoride silicate
Ca2SiO2F2 (ICDD-PDF # 35-2), accompanied by xonotolite Ca6Si6O17(OH)2 (ICDDPDF # 29-379),

hydroxyapatite Ca5(PO4)3OH (ICDD-PDF # 9-432)

KCa5(Si2O7)(Si6O15)(OH)F

(ICDD-PDF # 22-806)

(Figure 2-2B).30

and
GC2

miserite
exhibited
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greater peak intensity at 2θ = 28.1°, indicative of an increase in miserite content
(Figure 2-2C). GC3 displayed an XRD spectrum (Figure 2-2D) similar to that of GC2.
Finally, the GC4 spectrum showed a predominantly miserite crystalline phase,
accompanied by other minor phases (Figure 2-2E). The XRD spectra indicated the
successful synthesis of various GCs, consisting of variable amounts of calcium fluoride
silicate, xonotolite, hydroxyapatite and miserite.

2.3.3 Microstructure of Glass and GCs
SEM of fracture surfaces of glass did not reveal any indication of crystalline phases
(Figure 2-3A). Fracture surfaces of the GCs varied greatly with differences in the heating
schedule (Figure 2-3B-E). GC1 showed a mixture of spherulitic and acicular crystals
(Figure 2-3B). GC2 and GC3 showed predominant long laths with spherulitic crystals
(Figure 2-3C,D). In contrast, the principal microstructural features of GC4 were long
laths and logs with different aspect ratios (Figure 2-3E), consistent with the miserite
crystalline phase.
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Figure 2-1: Differential thermal analysis (DTA) of the experimental glass powder. (A)
Representative data from DTA of the experimental glass powder at 20°C/ min heating
rate shows the glass transition (Tg), first and second exothermic peaks (Tp1, Tp2) and
liquidus temperatures (Te). (B) Expanded exothermic peak for the glass at 20 °C/min
heating rate. ∆TFWHM is the full width at half maximum of the exothermic peak. (C) Typical
DTA plots of ln(Tp)2/Ø vs. 1000/Tp for the first and second peaks of the glass at heating
rates ranging between 10-50 °C/min, r is the correlation coefficient determined from
linear regression. Data are representative of 3 independent determinations.

Table 2-1: Differential thermal analysis (DTA) data for experimental glass fired from RT
to 1200 °C at five different heating rates ranging between 10 -50 °C/min. Data are means
(SD), n = 3.

Tg (°C)

Tp1 (°C)

Tp2 (°C)

Te (°C)

10

601 (2.7)

821 (1.9)

958 (2.1)

1073 (3.1)

20

603 (2.2)

841 (1.7)

983 (12.7)

1075 (1.4)

30

606 (3.4)

854 (1.3)

1024 (6.1)

1080 (25.7)

40

613 (2.2)

859 (1.6)

1031 (3.4)

1087 (28.8)

50

615 (2.5)

866 (1.4)

1038 (2.9)

1090 (4.5)

Heating rate
(°C/min)
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Table 2-2: Avrami exponents and activation energies of the glass crystallization.
Calculated from the first and second DTA exothermic peaks. Data are means (SD),
n = 3.

Tp1

Tp2

Avrami Exponent (nA)

1.1 (0.1)

2.8 (0.3)

Activation Energy (∆E, kJ/mole)

354 (24)

217 (6)

Table 2-3: Heat treatment schedules for experimental glass-ceramics.

Heating

Samples

Schedules
1

2

3
4

Heating rate*
(°C/min)

GC1

GC2

GC3
GC4

20

20

5
5

Heat Treatment
Temperature (°C)

Holding time* (h)

600

1

850

4

600

1

850

4

1000

2

600

1

850

4

600

1

850

4

1000

2

*Heating rate and holding time are experimental and not based on DTA data
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Figure 2-2: X-ray diffraction (XRD) of the as-quenched glass (A), GC1 (B), GC2(C), GC3
(D) and GC4 (E). GCs were treated at different heating rates, temperatures and holding
times, as specified in Table 3
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Figure 2-3: (A-E) Microstructure of fractured surfaces of as-quenched glass and GCs as
determined by scanning electron microscopy (SEM). (A) Amorphous glass. (B)
Microstructure of GC1 shows mixture of spherulitic and acicular crystals that represent
calcium fluoride silicate crystalline phase and other secondary crystalline phases. (C, D)
Microstructures of GC2 and GC3 reveal mixture of spherulitic and dominant long laths
crystals. (E) Microstructure of GC4 showing the principal phase of randomly oriented
long laths and logs with different aspect ratio that represent miserite crystalline phase.
(F) Macroscopic image of machined GC4 specimens: (i) drilled hole and grooves cut
along specimen perimeter, and (ii) shoulder preparation free of cracking and chipping.
Images are representative of 3 independent preparations.
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2.3.4 Physical and Mechanical Properties
The firing shrinkage of the GCs ranged between 14-18 %. The mean density and
Poisson’s ratio values for the as quenched glass and GCs ranged between 26662868 kg/m3 and 0.17-0.22, respectively (Table 2-4). The Young’s moduli (E values) for
the GC2, GC3 and GC4 were significantly higher than the as quenched glass (p<0.05).
These values ranged between 90-96 GPa, and GC4 exhibited the greatest E. The true
hardness (Ho) and fracture toughness (KIC) values of the GCs were significantly increased
by heat treatment of the glass. These values ranged between 4.33-5.27 GPa, and 3.814.77 MPa·m0.5, respectively. Additionally, the brittleness index (BI) values for the GCs
were significantly lower than that of the glass (p<0.05). GC4 exhibited the lowest value at
1.10 µm-0.5 (Table 2-4). Moreover, GC4 could be prepared smoothly and it did not exhibit
any surface cracking or chipping as a result of machining (Figure 2-3F). GC4 was
selected for further studies to assess its bioactivity in SBF and biocompatibility with
cultured cells, because of its excellent mechanical properties and machinability and it
exhibited miserite as the main crystalline phase compared to other GCs.
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Table 2-4: Physical and mechanical properties of experimental glass and glassceramics. Data are means (SD), n = 3. Different superscript letters denote that values
are significantly different (p<0.05) based on ANOVA and Tukey’s multiple comparisons
test.
Properties

Glass

GC1

GC2

GC3

GC4

Density (ρ, kg/m3)

2706 (3)

2666 (18)

2868 (12)

2818 (16)

2859 (37)

Poisson’s ratio (ʋ)

0.22 (0.30)

0.20 (0.02)

0.20 (0.03)

0.18 (0.02)

0.17 (0.01)

Young’s modulus
(E, GPa)

78.1 (0.5)a

80.1 (4.2)a

94.9 (2.4)b

89.8 (0.5)b

95.9 (2.5)b

True hardness
(Ho, GPa)

3.83 (0.09)a

4.33 (0.12)b

5.20 (0.42)c

4.84 (0.24)c

5.27 (0.26)c

Fracture toughness
(KIC, MPa·m0.5)

1.46 (0.14)a

3.81 (0.55)b

4.53 (0.60)c

3.90 (0.22)b

4.77 (0.27)c

Brittleness index
(BI, µm-0.5)

2.62 (0.05)a

1.14 (0.13)b

1.14 (0.18)b

1.24 (0.07)b

1.10 (0.05)b

2.3.5 Bioactivity of GC4
The SEM and EDX analyses of the GC4 specimens before and after soaking in SBF
demonstrated successful deposition of a calcium phosphate surface layer (Figure 2-4A,
B). As early as 1 week after immersion in SBF, the surface of the GC4 was covered with
a distinct coating (Figure 2-4Aii). Immersion of GC4 specimens for 4 weeks resulted in
the formation of a uniform surface layer having morphology similar to that of biomimetic
HA (Figure 2-4Aiv). EDX elemental analysis revealed an increase in the intensity of the
peaks attributed to Ca and P and gradual diminution of the Si peak after soaking in SBF
for increasing times (Figure 2-4B and Table 2-5). The calcium to phosphorous ratio
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(Ca/P) of the surfaces was in the range of 1.50-1.64, which is similar to bone-like apatite
(Ca/P ≈ 1.50) and approaching that of stoichiometric HA (Ca/P = 1.67).31
XRD spectra of the GC4 samples after immersion in SBF confirmed the formation of an
HA layer on the GC surfaces (Figure 2-4Cii-iv). The results showed attenuation of the
XRD peaks associated with GC4 after 1 and 2 weeks soaking in SBF, and the appearance
of peaks at 2θ = 26° and 32°, indicative of a poorly crystalline HA (ICDD-PDF # 09432). Moreover, after 4 weeks soaking in SBF, only peaks ascribed to HA were visible,
consistent with the formation of a thick apatite layer. Taken together, the SEM, EDX, and
XRD results confirmed the deposition of an HA surface layer after immersion of GC4 in
SBF, indicating its bioactivity.

Table 2-5: Energy dispersive X-ray spectroscopy (EDX) analysis of GC4 and molar Ca/P
ratio for different soaking times in SBF. Data are means (SD), n = 3.

Soaking time Si

Ca

P

Molar

(Week)

Atomic %

Atomic %

Ca/P ratio

Atomic %

0

21.38 (0.47) 17.19 (0.52)

0.12 (0.08)

------------

1

0.83 (0.25)

14.36 (0.21)

9.15 (0.07)

1.57 (0.01)

2

1.04 (0.33)

14.61 (0.33)

9.73 (0.14)

1.50 (0.03)

4

-----------

18.68 (0.65)

11.37 (0.28)

1.64 (0.02)
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Figure 2-4: Bioactivity of GC4. (A) SEM surface morphologies, (B) EDX spectra and (C)
XRD of GC4 before (i) or after soaking in SBF for 1 (ii), 2 (iii) or 4 (iv) weeks. (A) SEM
micrographs illustrate the surface morphology of the GC4 before soaking in SBF and the
formation of HA layer on the GC4 surfaces at low and high magnifications at different
times. (B) EDX spectra show the Si, Ca and P peaks before and after soaking in SBF.
(C) XRD confirmed the gradual formation of HA surface layer on the GC4 surfaces at
different soaking times in SBF. At 4 weeks, the XRD showed the spectrum of HA only
(PDF#19-272), indicating that GC4 is totally covered with HA layer (Civ).

2.3.6 Cell Morphology and Number on GC4 and Titanium
MC3T3-E1 osteoblast-like cells were cultured for 6, 24 and 72 h on GC4 and titanium
surfaces. Sand-blasted and acid-etched titanium (STi) was used as a positive control as it
is a biocompatible material approved for clinical implant applications.32 Fluorescence
images at different incubation times showed that cells attached to both GC4 and STi, but
spreading was markedly greater on GC4 at 6 h (Figure 2-5A-D). Cells on GC4 surfaces
were flattened and well spread with polygonal shapes. Higher magnification images
revealed the formation of stress fibers and few filopodia. In contrast, at 6 h the cells on
STi were spindle-shaped with distinct filopodia along the periphery of cells and longer
cytoplasmic extensions. There was no significant difference between the number of cells
present on GC4 and STi after 6 and 24 h incubation. However, by 72 h, there was a
significant increase in cell numbers on both GC4 and STi (Figure 2-5M, p<0.05),
consistent with proliferation of MC3T3-E1 cells on both surfaces. Also we note, there
were significantly greater cell numbers on GC4 than on STi at 72 h (Figure 2-5M,
p<0.05).
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Figure 2-5: Osteoblast attachment, spreading and morphology on GC4 and titanium.
MC3T3-E1 osteoblast-like cells were cultured for 6, 24 and 72 h on GC4 and titanium
(STi, control) substrata. Cells were then fixed and stained for filamentous actin (F-actin,
red) and nuclei (blue). (A-L) Images were obtained by fluorescence microscopy at low
and high magnifications. (M) Cell number was quantified by counting cells on GC4 and
STi discs after 6, 24 and 72 h. Cells were counted on 10 randomized fields on each
sample. Cell count data are means (SD) based on 3 independent experiments each
performed on triplicate samples. There was no significant difference between osteoblast
attachment to GC4 and titanium at 6 and 24 h. On the other hand, at 72 h, the cell
number was significantly greater on GC4 compared to STi (p<0.05) based on ANOVA
and Tukey’s multiple comparison tests.

Figure 2-6: Osteoblast proliferation on GC4 (A) and titanium (B). Cell numbers were
quantified after 1-7 days incubation using the CyQUANT® proliferation assay. Data are
means (SD) based on 3 independent experiments each performed on triplicate samples.
Because of different surface areas of GC4 and STi (113 mm2 and 177 mm2,
respectively), cell numbers on GC4 were normalized to the cell numbers on STi.
Different lowercase letters denote significantly differences (p<0.05) based on ANOVA
and Tukey’s multiple comparisons tests.
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2.3.7 Cell Proliferation on GC4 and Titanium
To further investigate the ability of these surfaces to support cell proliferation, MC3T3E1 cells were cultured for 1 to 7 days on GC4 and STi. Cell numbers were quantified
using the CyQuant® cell proliferation assay (Figure 2-6). Both GC4 and titanium
supported cell proliferation, with significant increases at days 5 and 7 on both substrata
(p<0.05). Taken together, results of the cell studies established that GC4 is at least
comparable to titanium in terms of its ability to support the attachment, spreading and
proliferation of osteoblast-like cells.

2.4 DISCUSSION
GCs are typically produced by melting glasses at high temperature (~1500 °C), which
results in significant fluorine loss and adversely influences the glass mechanical
properties.15 In the present study, the combination of wet-chemistry and spray-drying
resulted in a more homogeneous glass with lower melting point (1250 °C) compared to
similar compositions prepared by conventional methods.20 Maintaining the fluorine
content in the glass improves its sinterability and mechanical properties.33,34
The GCs synthesized in this study displayed good sintering characteristics by maintaining
the initial sample shape and integrity, features which are attributable in part to the
homogeneity of the precursor glass produced by wet chemistry.35 Additionally, the glass
powder was calcined at low temperature (200-700 °C) to remove adsorbed moisture and
impurities remaining from the synthesis stage.11
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Biomaterials are considered bioactive when a strong interfacial bond forms between the
implant and the surrounding bone tissue; through the formation of a carbonated HA layer
at the interface.13 This HA layer is similar in composition and structure to the apatite in
bone.36 The presence of an HA layer prevents fibrous tissue formation around the implant
that could hinder bone integration. In addition, the interfacial bond improves the load
distribution between the biomaterial and the surrounding bone and, as a result, diminishes
stress shielding.37 The GCs synthesized in this study are bioactive as evidenced by the
complete coverage of the GC4 surfaces with HA after 4 weeks of soaking in SBF. The
molar Ca/P ratio of the apatite surface layer ranged between 1.57 and 1.64, in good
agreement with the characteristics of biological HA.31
To our knowledge, there are currently no bioactive machinable non-metallic materials
used for dental implants. Therefore, it is relevant to compare characteristics of the
experimental miserite GC described in the present study to those of titanium (used
extensively for dental implants) and zirconia (recently introduced to the oral implantology
field.1,5 Both titanium and zirconia lack the bioactivity of miserite
The high stiffness of titanium dental implants (105-116 GPa) and dental zirconia
(~200 GPa) do not match that of human bone (4-20 GPa).6,38 This mismatch gives rise to
stress shielding,39 where the bone is inadequately loaded leading to bone resorption and
subsequent implant failure.37,39 Although, the stiffness of the miserite GCs developed in
the present study are still high (80-96 GPa), they are less than that of Ti and zirconia, and
could potentially reduce stress shielding.

85

Currently, zirconia dental implants have poor machinability as they undergo accelerated
aging due to development of micro cracks.8-10 Moreover, milling and machining of
zirconia implants negatively impact the final implant fracture strength.9,40 The good
machinability of the experimental GCs is attributed to the randomly oriented, interlocking
lath crystals.34
When miserite GC is machined, micro cracks developed at the glass/crystal interfaces
will be hindered by the interlocking lath crystals, which act as a barrier against
catastrophic crack propagation.21 BI has been proposed as a quantitative measure of
machinability, where ceramics with a BI value less than 4.3 µm-0.5 are considered
machinable.26 This was the case for GC4, with a BI of only 1.1 µm-0.5. Moreover, GC4
could be milled into different shapes without cracking, indicating its potential for the
production of dental implants by CAD-CAM technology.
Attachment of cells of the osteoblast lineage to the biomaterial surface is an initial step
towards the formation of new bone tissue surrounding the implant.32 The osteoblast-like
cell line, MC3T3-E1, used in the present study has been widely used to assess the
biocompatibility of Ti dental implant materials.32 Osteoblast-like cells attached, spread
and proliferated on GC4, which indicates that GC4 is biocompatible. Interestingly, cell
morphology differed on the relatively smooth surface of GC4 and the rougher surface of
STi, likely reflecting differences in surface chemistry and topography. These results are in
agreement with previous studies, which demonstrated that osteoblasts attach, spread and
proliferate differently on smooth surfaces as compared to rough surfaces.32,41 At 24 and
72 h, cells exhibited specific morphology and actin stress fibers were clearly visible.
Moreover, both the GC4 and STi surfaces supported cell proliferation.
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When the synthesized transparent glass was heat treated and crystallized to form GCs, it
became white opaque. It likely lost transparency as a result of random light scattering and
the difference in refractive index between the crystal and the parent glass.42 Regardless,
GC4 is esthetically acceptable as a dental implant when compared with Ti dental implants
that may show a grayish line at the gingival margin. The metal-free GC dental implant
preserves the natural color of the soft tissue surrounding the dental implant and improves
the esthetic outcome of treatment.
Preliminary studies were performed on these GC, assessing their chemical durability in
acetic acid and degradation in tris-buffered solution (Appendix B). Results of these initial
studies suggested that miserite GC was not sufficiently stable to meet the requirements of
dental restorations exposed to the oral environment or implanted in bone. These data
motivated us to modify the GC composition, keeping the favorable mechanical, physical
and biological properties, while improving chemical durability. Synthesis and
characterization of the resulting wollastonite glass-ceramics are described in Chapters 3
and 4.

2.5 CONCLUSIONS
Glass ceramic containing miserite [KCa5(Si2O7)(Si6O15)(OH)F] as the dominant phase
was prepared by wet chemistry, spray-drying and sintering (bulk crystallization). The
microstructure of GC4 was primarily interlocked log and lath crystals, which contributed
to high KIC (4.77 MPa·m0.5), as well as excellent machinability. In vitro tests showed that
miserite GC is bioactive and supports the attachment and proliferation of osteoblast-like
cells comparable to clinically proven titanium surfaces.
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CHAPTER 3
SYNTHESIS AND CHARACTERIZATION OF WOLLASTONITE
GLASS-CERAMICS FOR DENTAL IMPLANT APPLICATIONS
This chapter describes a novel approach for the synthesis of GCs with mechanical,
physical and chemical properties required for non-metallic dental implant applications.
The contents of this chapter have been reproduced (with modifications of the glasses and
glass-ceramics nomenclature) from a manuscript that has been accepted for publication
in Dental Materials (Saadaldin et al, Dental Materials, DEMA-D-13-00398R1).

3.1 INTRODUCTION
Glass-ceramics are polycrystalline materials with an inorganic-inorganic microstructure
that were prepared from base glass by controlled crystallization. This was achieved by
subjecting glasses to regulated heat treatment, which resulted in the nucleation and
growth of one or more crystal phases within the glass. GCs have diverse physical,
chemical, mechanical, optical and biological properties that can be modified with glass
composition and heat treatment conditions.1 As a consequence of the continuous need of
the general public as well as the dental professionals to eliminate dental metal-based
products, there is a trend towards GCs and ceramic-based materials in the biomedical
field.2 Yttrium-stabilized tetragonal zirconia polycrystalline has been used extensively as
a material of choice for ball heads in total hip replacement since 1980s, and it became
commercially available as non-metallic dental implants in 2000s, owing to its strength,
fracture resistance and appropriate optical properties.3 However, zirconia undergoes aging
through low-temperature degradation phenomenon that is moisture/water related and
unfavorably affects its physical properties. In 2000, several hundreds of hip prosthesis
failed over a short period of time. These failures were ascribed to an accelerated aging of
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the zirconia femoral head in particular batches.4 Additionally, literatures showed that
zirconia is correlated with two types of radiation impurities, alpha and gamma. Alpha
radiation has been observed in a significant amounts and it could harm soft and hard
tissues’ cell due to their high ionization.5,6
The wollastonites (CaSiO3) are white glassy silicate minerals that occur as masses or
tabular crystals of metamorphosed limestone. A silica chain GC that contains crystalline
apatite and β-wollastonite (AW) was introduced in an MgO-CaO-SiO2-P2O5 glassy matrix
and it showed an excellent bioactivity, biocompatibility, machinability and adequate
mechanical properties such as Young’s modulus (117 GPa), compressive strength
(1080 MPa), and bending strength (215 MPa).7 AW has been used for orthopedic
applications–artificial vertebrae, intervertebral discs and iliac crest prostheses.7,8 Kokubo
proved that the mechanical strength of the AW was significantly unaffected in simulated
body fluid at 36.5 °C and presumed that it can withstand a bending stress of 65 MPa in
the human body environment for over 10 years.7 Yet, the fracture toughness of the AW
had relatively low values (2-2.5 MPa.m0.5); therefore it’s limited to non-load bearing
applications. And we note that, a custom AW prostheses production by conventional lost
wax casting can be difficult as a result of the surface crystallization.7 However, because
of its excellent bioactivity, AW was used as a coating on different substrates such as
titanium alloys9 or as a composite scaffold by incorporation of AW with other
materials.10,11
Fracture toughness (KIC) measures the resistance of a material to cracks propagation and
the ability to prevent the initiation of catastrophic fracture. Indentation test has been
considered as an accurate procedure to measure the fracture toughness for brittle
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materials, like ceramics and GCs. The indentation method has the advantages of
simplicity and economy; where only small specimen area is needed, hence the technique
is suited for comparative evaluation.12
Chemical durability affects the clinical performance of dental materials. With a wide
range of pH and temperature, dental materials should resist chemical degradation and
dissolution. Chemical degradation of ceramic dental materials could lead to structure’s
weakening and surface roughness as a result of surface-ion exchange. This phenomenon
leads to increased plaque attachment onto the biomaterials and intensify abrasion
potential against opposing natural teeth and other restorative materials.13
The brittle behavior of the GCs makes them sensitive to milling and machining; therefore
the development of machinable GCs for dental implant applications is considered a
significant progress. A machinable dental implant material can be introduced to CADCAM technology and customized implants for different clinical cases can be fabricated,
in addition to the possibility of the modification and adjusting of the implant at the time
of surgical insertion. Machinable GCs can be used as one-piece dental implants where the
upper part can be prepared to produce the abutment unit and get rid of multiple
component implants i.e. fixture, screw and abutment.
The objectives of this study were to synthesize machinable wollastonite GCs with
mechanical properties suitable for dental implant applications, to assess their chemical
durability using acetic acid and tris buffered solution at different time points and evaluate
their fracture toughness following chemical degradation testing.
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3.2 MATERIAL AND METHODS:
3.2.1 Glass Synthesis
Transparent glass frits were synthesized by wet chemical methods through four steps. In
the beginning, the desired glass compositions in weight % (Table 3-1) were prepared by
mixing batch ingredients {Si(C2H5O)4, Al(NO3)3.9H2O, Ca(NO3)2.4H2O, CaF2, KNO3,
H3BO3, Ce(NO3)3.6H2O and Y(NO3).6H2O} in aqueous solution using excess deionized
water, and kept stirred overnight to commence hydrolysis and polycondensation of metal
alkoxides. This was followed by spray drying of the solutions at a feed flow rate of
10 ml/min, inlet air temperature of 160 °C and outlet air temperature of 80 °C using a 190
mini spray-dryer (BÜCHI, Switzerland). The spray-dried powders were calcined by
means of a Ney 650 vacuum oven (Ney-Barkmeyer, USA) through sequential heating
schedules at 200, 500 and 700 °C for 2 h. Finally, the calcined powders were melted in an
uncovered platinum crucible at 1350 °C for 3 h in a high temperature furnace
(Thermolyne Corporation, USA), followed by quenching in iced-water to obtain the glass
frits.
Table 3-1: Chemical composition (wt%) of the experimental glasses
Glass

SiO2

Al2O3

CaO

CaF2

K 2O

B 2O 3

P 2O 5

CeO2

Y 2O 3

G-A

55

2

17

12

5

3

1.5

1.5

3

G-B

59

1

15

12

5

3

2

0

3

G-C

50

2

20

12

7

3

3

0

3

component
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3.2.2 Differential Thermal Analysis
Crystallization kinetic parameters of the glasses (G) were determined using SDT Q600
V20.5 Build 15 (TA Instruments, USA) at different five heating rates (10-50 °C/min),
starting from room temperature up to 1200 °C under air atmosphere; for each heating rate,
three-independent runs were carried out (n=3). The average sample weight was 20 mg
and an equivalent weight of α-Al2O3 was used as a reference. The activation energy (∆E)
was calculated from the plot of ln (Tp)2/Ø vs. 1000/Tp using the Kissinger equation,14
where Tp is the exothermic peak (°C) as determined from the DTA spectra and Ø is the
heating rate (°C/s). The Avrami exponent (nA) was calculated using the Augis-Bennett
equation13 from the full width at the half maximum of the exothermic peak at 20 °C/min.
nA is related to the directionality of crystal growth, lower values (≈1) of nA reflected
surface crystallization, whereas nA values above 1.5 indicated bulk crystallization.15

3.2.3 Glass-Ceramics Preparation
Glass powders were mixed with 4% polyethylene glycol as a binder and ball-milled using
a planetary ball mill, Pulverisette 7 (Laval Lab, USA). Cylindrical ingots (6 mm x10 mm)
and disk specimens (11 mm x 1 mm) of the glass powders were produced by cold
pressing using a Carver laboratory cold press (Carver, USA) in stainless steel dies at 40
MPa. Pressed glass specimens were heated for 1h at the glass transition temperature that
was obtained from DTA spectra for the nuclei formation. Afterward the temperature was
subsequently raised to the crystallization temperatures determined from the DTA
exothermic peaks and held for 4 h, Table 3-2.
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Table 3-2: Optimal heat treatment schedules for the experimental glass ceramics based
on the DTA data.

Samples
GC-A
GC-B
GC-C

Heating rate*

Heat Treatment

(°C/min)

Temperature (°C)

Holding time* (h)

20

700

1

950

4

750

1

1000

4

700

1

950

4

10
10

* Heating rate and holding time were experimental and not based on DTA data

3.2.4 X-Ray Diffraction
Crystalline phases of the GCs were analyzed by XRD using a Rotaflex RTP 300 RC
(Rigaku Co, Japan) operating on CoKα radiation at 45 kV and 160 mA. Spectra were
collected in the 2θ range between 2 and 82°, with 0.05° step and 10°/min scan speed.
Bragg’s Law was used to calculate 2θ for equivalent CuKα radiation.16

3.2.5 Microstructure
Prior to SEM analysis, samples were mounted on aluminum stubs with silver paint and
then coated with 3 nm osmium metal (Filgen OPC 80T). The fracture surfaces of the
glasses and GCs were examined using LEO 1540XB FIB/SEM (Zeiss, Germany)
equipped with an energy dispersive X-ray spectroscopy (EDX) system.
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3.2.6 Dynamic Elastic Constants of the GCs
The dynamic elastic properties of the synthesized GCs and yttria-stabilized zirconia (YZ)
ceramic control (Vita Zahnfabrik, Germany) were evaluated by ultrasonic method.17 The
density of each specimen (ρ) was determined using the Archimedes method in deionized
water at room temperature. The dynamic elastic moduli and Poisson’s ratios (n=3) were
calculated from the velocities of the longitudinal (VL) and shear (VS) waves which were
determined using lithium niobate crystals that were used for transmitting and receiving
waves at 10 MHz resonant frequencies The equations used for the calculation are reported
elsewhere.17,18

3.2.7 True Hardness and Fracture Toughness Evaluation
The true hardness (Ho) and the fracture toughness (KIC) of the GCs and YZ specimens
were determined using a Buehler Micromet 5114 Knoop and Vickers micro hardness
indenter, (Buehler, USA), respectively. The specimens were embedded in resin and
polished (n=3). To calculate the Ho, a series of Knoop indentations were performed on
each specimen at six consecutive loads (0.49-9.9 N). The average diagonal lengths of the
Knoop indentations were measured using Buehler OmniMet

MH

T7.2 Rev.2 optical

microscope equipped with a digital camera and computer software (Buehler, USA).
Indentation lengths were plotted vs. the square root of the different load values, and Ho
was calculated from the slope of the linear regression line.19 KIC of the GCs and YZ were
determined by measuring the diagonals of the Vickers indentation and the crack lengths
using the Lankford equation.20 The average KIC value was calculated from 45
indentations performed on three specimens at a load of 9.8 N.
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3.2.8 Chemical Durability
The ISO standard 678221 was used for assessing the chemical durability of the GCs and
YZ. Triplicate samples were washed in distilled water in a digital ultrasonic bath (Eumax,
China) and dried in a Temp Master “A” furnace (JELRUS, USA) at 150±5 °C for 4 h.
The weight of the samples and the total surface area were determined to the nearest 0.1
mg and 0.1 cm2, respectively. Specimens were soaked in 20 ml of pre-heated (80 °C) 4 %
acetic acid (AC) solution in glass bottles. The bottles were placed in a vacuum oven
(VWR, USA) at 80 °C for 16 h. Then the specimens were washed with distilled water in
the ultrasonic bath, dried at 150±5 °C until a constant weight was reached. The chemical
durability was analyzed by measuring of the specimens weight loss/ unit area (wt/A;
µg/cm2). Later, to assess the effect of the chemical dissolution on the mechanical
properties of the materials, the KIC were re-measured for chemically tested specimens.

3.2.9 Degradation Testing
The degradation testing was performed according to ISO standard 10993-14.22 The test is
based on a buffered solution that simulates the body’s normal pH level. TRIS-HCl
buffered solution (TBS) was prepared by dissolving tris (hydroxymethyl) aminomethane
in water; the pH of the solution was adjusted to 7.4±0.1 with an appropriate amount of
1 mol/L HCl acid at 37 °C. Triplicate specimens were washed in a digital ultrasonic bath
(Eumax, China) and dried at 150±5 °C in a Temp Master “A” furnace (JELRUS, USA).
Samples’ weights were measured, and then the specimens were soaked in freshly
prepared TBS in polypropylene containers. The bottles were placed in a MaxQ 5000
circular agitated controlled-temperature chamber (Thermo Scientific, USA) at 37 °C for
different timelines (1, 3, 7, 30, 60, 90, and 120 days). At the predetermined time point the
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specimens were washed with distilled water in the ultrasonic bath, dried to constant mass
and weighed. The degradation of each sample was determined by calculating the
percentage weight loss. In a similar manner as described above, the KIC for the specimens
that were soaked for 120 days in TBS were re-measured.

3.2.10 Machinability
Qualitative evaluation of the machinability of the GCs was conducted through drilling
holes, grooves, bevels as well as preparing shoulder finish lines on GCs’ ingots and discs
of different thicknesses. Additionally, quantitative assessment was done by calculating
brittleness index (BI), which is the ratio of the hardness to the fracture toughness. The
lower the brittleness index, the higher the machinability.23

3.2.11 Statistical Analyses
One-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test
at a significance value of p<0.05 was used to analyze differences among groups.
Nonlinear regression analysis was used to evaluate the degradation rates at different
timeline. The KIC values for the chemically tested specimens at 120 days were analyzed
with simple main effect analysis and Tukey’s multiple comparisons test, p<0.05.

3.3 RESULTS
The manufacturing process used in this study resulted in clear transparent amorphous
glasses prior to any further heat treatment used to produce the final GCs.
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3.3.1 Differential Thermal Analysis of the Glasses
The DTA spectrum of each glass displayed the glass transition temperature (Tg) as a
shoulder endothermic peak, the crystallization temperature of the glass (Tp) as an
exothermic peak, and the liquidus temperature (Te), which resulted from decomposition
and disintegration of the crystalline phases and illustrated as an endothermic peak,
Figure 3-1A. Table 3-3 displayed the nA values and the activation energies of
crystallization of the glasses. G-A had two exothermic peaks and the nA values for both
peaks indicated bulk crystallization. On the other hand, G-B and G-C had one exothermic
peak. The nA value for G-B signified surface crystallization, while that for G-C of 1.8
denoted bulk crystallization. The activation energies of crystallization of the glasses (∆E)
were calculated from the slope of the regression lines, ln (Tp)2/Ø vs. 1000/Tp, as
demonstrated in Figure 3-1B. The values of the glasses’ ∆E ranged between 257 and
360 kJ/mole, and G-B exhibited the highest value.
Table 3-3: Avrami exponents and activation energies of the experimental glasses. Data
are mean (SD) of three independent runs at 20°C/min. *Calculated from second
exothermic DTA peak.

Avrami

Activation Energy

Exponent (nA)

(∆E, kJ/mole)

G-A

1.7(0.06)

257(8)

G-A*

1.6(0.18)

308(23)

G-B

1.2(0.04)

360(16)

G-C

1.8(0.04)

317(14)

102

A
G-C
G-B
G-A

B

G-B

G-C

G-A

G-A
G-B
G-C

Figure 3-1: (A): Representative DTA curve of the G-A, G-B and G-C powders at 20 °C
heating rate. (B) Typical DTA plots of ln Tp2/Ø vs. 1000/Tp for the first peaks of the
glasses at heating rates ranging between 10-50 °C/min. Tp is the exothermic peak as
determined from the DTA spectra and Ø is the heating rate (°C/s). The coefficient of
determination calculated from linear regression for G-A, G-B and G-C were 0.988, 0.983
and 0.996, respectively. Data are representative of 3 independent runs.
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3.3.2 XRD Analysis of GCs
The principal crystalline phase for the GC-A and GC-C was wollastonite (CaSiO3/ ICDDPDF # 10-489), accompanied by hydroxyapatite (Ca5(PO4)3OH/ ICDD-PDF # 9-432) and
Fluorite (CaF2/ ICDD-PDF # 21-159) as shown in Figure 3-2A,C. The XRD spectrum of
GC-B, Figure 3-2B, illustrated the same crystalline phases as GC-A and GC-C with an
extra peak at 2θ = 21.6°, indicating the presence of cristobalite (SiO2/ ICDD-PDF # 391425) as an additional crystalline phase.

Wollastonite
Hydroxyapatite
Fluorite
GC-C

Cristobalite
GC-B

GC-A

Figure 3-2: XRD analysis of GC-A, GC-B and GC-C.
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Figure 3-3: SEM micrograph of sintered GC-A (A), GC-B (B) and GC-C (C).
Microstructure of the GCs showed acicular interlocking crystals
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3.3.3 Microstructure of the GCs
Fracture surfaces of the GCs showed dense acicular interlocking log crystals, which are
attributed to wollastonite crystals, Figure 3-3A-C.

3.3.4 Physical and Mechanical Properties
The density and Poisson’s ratio for the GCs were 2656-2891 kg/m3 and 0.20-0.21,
respectively. These values for YZ (the control material) – 6120 kg/m3 and 0.42,
respectively, (p<0.05) were significantly higher as shown in Table 3-4. The E values for
the three GCs were 89-100 GPa; though, it was significantly higher for the YZ (212 GPa),
p<0.05. Furthermore, the Ho values were 4.85-5.17 GPa. These values were not
significantly different among the three GCs, (p<0.05). YZ had significantly higher Ho
value of 9.64 GPa, p <0.05. We note that there were significant differences among the
measurements for the KIC of GC-A, GC-B, GC-C and YZ that exhibited the significantly
higher value of 10.02 MPa·m0.5, (p<0.05). BI of the GCs ranged between 0.99 and
1.16 µm-0.5 indicating excellent machinability. This quality was confirmed by the
quantitative assessment of crack-free and smooth preparation of GCs samples without
fracturing or chipping.

3.3.5 Chemical Durability
The chemical solubility of GC-B samples in 4 % AC, pH=2, were significantly lower
than those of GC-A and GC-C (p<0.05) as shown in Table 3-4. The wt/A of GC-B
satisfies the ISO specification (less than 100 µg/cm2), which means that it can be exposed
to the harsh oral cavity environments and it is comparable to the wt/A value for YZ. The
significantly lower chemical durability for GC-A and GC-C (higher than 100 µg/cm2 and
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lower than 2000 µg/cm2) indicated that these GCs could be used as substructure ceramics
that are veneered with other dental biomaterials and should not be exposed to the oral
cavity environment. The KIC values of the specimens following chemical durability
testing in AC for 16 h were not significantly different when compared with the KIC values
of the original untested specimens (ANOVA p<0.05), Figure 3-4.

Table 3-4: Physical, mechanical and chemical properties of the experimental glass
ceramics and yttria-stabilized zirconia (YZ). Data are means (SD), n = 3. Different
superscript letters denote that values are significantly different (p<0.05) based on
ANOVA and Tukey’s multiple comparisons test.

Properties

GC-A

GC-B

GC-C

YZ

Density
(ρ, kg/m3)

2891(6.1) a

2656(20.8) b

2713 (38.5) b 6120(32.5) c

Poisson’s ratio (ʋ)

0.20(0.020)

0.21(0.070)

0.20(0.009)

0.42(0.100)

Young’s modulus
(E, GPa)

89(1.27) a

90(2.98) a

100 (2.09) b

212(4.41) c

Fracture
toughness
(KIC, MPa·m0.5)

4.62(0.04) a

5.58(0.32) b

4.91(0.26) a

10.02(0.50) c

True hardness
(Ho, GPa)

5.17(0.22) a

5.15(0.47) a

4.85(0.12) a

9.64(0.13) b

Brittleness index
(BI, µm-0.5)

1.12(0.06)

1.16(0.10)

0.99(0.06)

-------

Mass loss/Unit
area (µg/cm2)

1431(96.80) a

100(12.25) b

987(89.16) c

101(8.84) b
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GC-A

GC-B

GC-C

Figure 3-4: Fracture toughness values before and after soaking GCs specimens in
4 %acetic acid (AC) for 16 hours at 80 °C and tris buffered solution (TBS) for 120 days at
37 °C. Data are mean values (SD), n=3. ANOVA and Tukey’s multiple comparisons test
were used to analyze the results for each material (p<0.05). There was no significant
difference between the original fracture toughness values and the values of chemically
tested specimens in both solutions for GC-A, GC-B and GC-C.

3.3.6 Degradation Test
Figure 3-5A illustrates the variation of degradation rates of soaked GCs samples in TBS
for different time durations starting from 1day up to 120 days. The percentage
degradation increased incrementally as a function of soaking time. All GCs exhibited no
weight loss at the first day. Afterward, the degradability values of the GCs increased
slowly with different percentages. After 120 days, the GC-A had a weight loss of 2.9 %
and it was significantly higher than that of GC-B and GC-C that were 0.36 % and 0.85 %,
respectively, (p<0.05), revealing very low solubility of GC-B and GC-C, Figure 3-5B.
The KIC values of the specimens following chemical degradation testing for 120 days
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were not significantly different (ANOVA p<0.05) when compared with the KIC values of
the original untested specimens, Figure 3-4.

GC-A
GC-B
GC-C

GC-A

GC-B

GC-C

Figure 3-5: (A) Degradation test of the experimental GCs showing weight loss
percentage of the GCs specimens after soaking in tris buffered solution from 1 day up to
120 days. Exponential growth equation was used to show nonlinear fit curve for the
degradation rates at different timeline. (B) Weight loss percentages of the GC-A, GC-B
and GC-C at 120 days time point soaking in tris buffered solution. GC-B showed the
least weight loss percentage. Different letters represent significant statistical difference
(Simple main effect analysis and Tukey’s multiple comparisons test, p<0.05). Data are
mean values (SD), n=3.
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3.4 DISCUSSION
The preparation of the precursor glass plays an important part in the properties of the
manufactured GCs. In this study the glasses were synthesized by sol-gel chemistry,
followed by spray drying and calcination, melting and quenching; all these steps improve
the glass homogeneity and lead to good sintering characteristics of the resultant GCs.24
The SEM images of the GCs confirmed the formation of dense acicular interlocking
crystals that ascribed to wollastonite crystals. These blade-like crystals are thought to
contribute to the strength and toughness of the GCs through blunting and crack seizing
leading to the prevention of crack-propagation and achieve the high values of the fracture
toughness.1
The Young’s modulus of elasticity (E) is of great importance for dental GCs, and it
represents the stiffness of a material within the elastic range measurement of the stiffness
biomaterials. A mismatch between the E for bone (4-20 GPa)25,26 and implant
biomaterials could lead to stress shielding phenomenon.27 The young’s modulus of
elasticity influences the ability of the implant to transmit stresses to the adjacent bone and
sustains tissue vitality over time. The lower the Young’s modulus of implant material, the
better the load distribution to the surrounding tissue with the possible beneficial result of
new bone formation.28,29 The E value of ~210 GPa for the commercial non-metallic dental
implant “yttria-stabilized tetragonal zirconia”

6

is similar to that of In-Ceram zirconia.

These values are 10x higher than that of cortical bone tissue. The E value for the
experimental wollastonite GCs (89-100 GPa) is half of that for zirconia dental material,
but it still higher than that of bone tissue.
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XRD data analysis revealed that all experimental GCs had wollastonite as the principal
crystals along with different proportions of secondary crystalline phases. However, GC-B
has cristobalite as additional crystalline phase, which is the stable form of silica (SiO2).
The formation of cristobalite in GC-B is due to the higher silica within its chemical
composition.
One-piece dental implants should be chemically durable to withstand the aggressive oral
environments e.g. diverse chemical fluids, broad range in pH and periodic high
magnitude mechanical forces that may accelerate GC degradation by corrosion and
surface wear.1,30 In this study, the chemical durability of the GCs was tested in 4 % AC
(pH 2) for 16 h at 80 °C as well as in TBS (pH 7.4) up to 120 days at 37 °C to simulate
the body conditions whether the material is exposed to the oral environments or
implanted in bone and soft tissue. The chemical durability of GC-A and GC-C in AC was
substantially higher than 100 µg/cm2 but less than 2000 µg/cm2. As a result, these GCs
can be used as core materials but cannot be exposed to oral fluids.21 On the other hand;
GC-B exhibited the least degradation rate (0.36% weight loss at 120 days soaking in the
TBS) and the least wt/A (100 µg/cm2) in AC. These results can be related to the
cristobalite, which is the chemically stable crystalline phase.31 The wt/A of GC-B is
comparable to that of YZ that is used for dental restoration and is considered to be a
chemically stable dental material.2 The wt/A and degradation rates of the three GCs were
dissimilar because of the different initial chemical compositions (Table 3-1), which were
reflected on the crystallization kinetics of the parent glasses and their mechanical and
chemical properties.
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In the current study, we tested the chemical stability of the GC in acidic environment and
in balanced pH based on ISO 6872 (for dental ceramics) and ISO 10993-14 (Biological
evaluation of medical devices). However, recent study revealed that basic pH buffer
environment (pH of 10) resulted in a complete breakdown of the silica network of the
dental ceramics.32 We plan to evaluate the chemical stability of the synthesized GC in
basic solution in a future study.
The mechanical properties of the chemically tested GCs were re-measured to evaluate the
effect of the degradation and dissolution on their mechanical behavior. E, Ho and KIC
were assessed, but only the data of the KIC were shown in this study for two reasons.
First, the equation and the calculation of KIC include both E and Ho and hence any
changes of these parameters will be reflected on KIC.20 Secondly, the KIC is considered as
an essential and starting point for the evaluation and selection of the biomaterials for
clinical applications and it determines the aspects of brittle material mechanical
behavior.12 Interestingly, there was no significant difference between KIC values for the
original and chemically-tested specimens indicating that the mechanical behavior of the
chemically-tested specimens were not affected in spite of the fact of different chemical
degradation and wt/A of the GC samples. To our knowledge we are the first group who
evaluated the KIC of the GCs following chemical durability testing.
Boccaccini23 proposed the brittleness index (BI) as a quantitative evaluation of
machinability. The BI values of the wollastonite GCs were lower than 4.3 µm-0.5
indicating excellent machinability. These results were confirmed by cutting, milling and
preparing GC specimens smoothly without developing cracks, Figure 3-6. Interlocking
crystals contributed to the machinability of the materials by acting as barriers to suppress
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crack propagation.33 Machinable GC can be prepared by the CAD-CAM system that
enables customization of implants for individual patients. Additionally, the upper part of
the GC can be prepared inside patient’s mouth to function as an abutment part and to
receive the crown.

Figure 3-6: Representative image of machined GC-B specimens. Holes and grooves
were cut on 1 mm thick disks and bevels with shoulder finish line were prepared on GC
ingot. The preparation was going smooth without chipping or developing cracks.
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3.5 CONCLUSIONS
High strength, chemically durable and machinable sintered GCs were prepared with
different chemical compositions; the experimental GCs had different crystallization
kinetics that affects the mechanical and chemical properties of the GCs. The wollastonite
was the main crystalline phase with other secondary crystalline phases–hydroxyapatite
(Ca5(PO4)3OH) and Fluorite (CaF2) for the three GCS. Yet, GC-B had an additional
crystalline phase–cristobalite (SiO2) that could be the main reason for showing an
excellent chemical durability. Microstructures of GCs revealed acicular interlocking
crystals that were responsible for the high KIC and to the outstanding machinability.
Machinable GC-B may be considered as a unique, convenient and propitious biomaterial
for immediate non-metallic one-piece dental implant applications as alternative to the
commercial dental implants.
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CHAPTER 4
BIOACTIVITY AND BIOCOMPATIBILITY OF A NOVEL
WOLLASTONITE GLASS-CERAMIC
This study was performed to further characterize the previously synthesized wollastonite
GC. In this chapter, the bioactivity and biocompatibility of the wollastonite GC were
evaluated and they were compared to those of In-Ceram yttria partially stabilized
zirconia. The contents of this chapter have been submitted for publication.

4.1 INTRODUCTION
Zirconia dental implants were introduced as an alternative to titanium dental implants. In
addition to fulfilling the patients’ demand for a metal-free implant, zirconia dental
implants overcome some aesthetic problems associated with titanium dental implants.1
Zirconia implants exhibit unique and favorable physical, mechanical and optical
properties, while also having excellent resistance to corrosion because of their chemical
stability and bio-inertness.1-5 Good biocompatibility of zirconia was attributed to
biointegration, which “is the occurrence of continuity of ceramic implant to bone without
intervening space at bone/implant interface”,6 similar to the osseointegration obtained
with titanium dental implants.4,6 Recently, various ceramic implant systems made of
yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) have become commercially
available.5,7 However, adequate biological data on zirconia dental implants is not yet
available due to the lack of long-term clinical studies.7,8
The clinical usage of zirconia is limited for many reasons. First, machining and/or surface
modifications of zirconia are difficult.5,9 Second, radioactive elements with long half-lives
can accompany zirconia. The presence of segregated clusters of radionuclides could harm
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the surrounding tissues.5,6,10 Third, Y-TZP is susceptible to aging through lowtemperature degradation that compromises long-term clinical performance and increases
the possibility of subsequent catastrophic implant failure.7,9
Commercial dental implants (titanium and zirconia) are bioinert and lack bioactivity.
Biomaterials researchers are interested in improving the bioactivity of implant materials
through different techniques; the most common method is bioactive coatings that exhibit
bone-bonding ability.11-13 However, these coatings can de-bond at different locations on
the implant surface or can undergo non-uniform degradation, which would impair
osseointegration at the interface between the coated implant and bone.14 Another
approach to improve bioactivity is to integrate HA as a composite within the implant
material. As a result, the bioactivity and biocompatibility of the implant material is
improved,15 but additional investigation is needed to evaluate the effect of the
incorporated HA on the mechanical properties and clinical in vivo performance of these
composite materials.9
Biocompatibility is the ability of a material to provide successful clinical service in a host
without producing allergic or/and toxic reactions in the surrounding tissues or adverse
systemic reactions.16 The biocompatibility of zirconia has been evaluated; the bone
response of zirconia and the inflammation adjacent to zirconia have been shown to be
satisfactory.2 MCT3T-E1 osteoblastic cells displayed active cellular reactions on zirconia,
including initial cell attachment, proliferation and differentiation.17,18 Other studies
demonstrated that Y-TZP showed good attachment and proliferation of osteoblastic cells
regardless of surface treatment or topography, with no signs of toxic or carcinogenic
outcomes.19-21
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Although commercial dental implants, both metallic and ceramic, have good clinical
performance, both have the limitations of being non-bioactive and non-machinable.1,-2
Our group has synthesized and characterized a novel WGC for one-piece dental implant
applications (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1) with the
appropriate strength, chemical durability and machinability. In the current study, the
bioactivity and biocompatibility of the WGC were evaluated and compared to In-Ceram
yttria partially stabilized zirconia (YZ). WGC was found to be bioactive with
biocompatibility comparable to that of YZ, making WGC a promising material for dental
implant applications.

4.2 MATERIALS AND METHODS
4.2.1 Materials
The synthesis of a high strength, chemically durable and machinable WGC in the system
(SiO2-Al2O3-CaO-CaF2-K2O-B2O3-P2O5-CeO2-Y2O3)

and

characterization

of

its

mechanical and chemical properties were previously reported (Saadaldin et al, accepted
for publication, DEMA-D-13-00398R1). In-Ceram yttrium partially stabilized zirconia
(YZ, Zahnfabrik, Berlin, Germany) was used as a control.

4.2.2 Bioactivity
In vitro bioactivity of WGC and YZ was evaluated by soaking samples (11 mm x 1 mm)
in simulated body fluid (SBF) under biomimetic conditions (37 °C, pH 7.24). The
specimens were soaked for 1, 2 and 4 weeks in SBF that had inorganic ion concentrations
similar to those of human blood plasma.22 SBF was refreshed every week. At the
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scheduled time, the specimens were thoroughly rinsed, dried and then evaluated as
described below.

4.2.2.1 Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray
Spectroscopy (EDX)
The surface layer of the WGC and YZ specimens was imaged before and after soaking in
SBF using high resolution scanning electron microscopy (LEO 1540XB FIB/SEM Zeiss
Nano Technology Systems Division, Germany) equipped with an EDX spectrometer.
Prior to SEM and EDX assessment, all samples were coated with 3 nm osmium metal
using a Filgen OPC 80T osmium plasma coater.

4.2.2.2 X-Ray Diffraction (XRD)
The formation of an apatite surface layer on the soaked specimens was assessed by XRD
using a rotating anode X-ray diffractometer (Rotaflex RTP 300 RC, Rigaku Corp., Japan)
operating on Co Kα radiation at 45 kV and 160 mA. Spectra were collected in the 2θ
range between 2° and 82°, with 0.05° steps and 10°/min scan speed. 2θ for equivalent Cu
Kα radiation was calculated using Bragg’s Law.23

4.2.3 Biocompatibility
4.2.3.1 Osteoblast Attachment and Morphology
Newborn mouse calvaria-derived MC3T3-E1 Subclone 4 preosteoblastic cells were
obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA).
MC3T3-E1 cells are similar to primary calvarial osteoblasts in their expression of Runx2,
bone sialoprotein and osteocalcin, and their ability to form bone-like matrix in vitro and
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in vivo.24 WGC and YZ discs (11 mm x 1 mm) were cleaned and sterilized using an
argon-based plasma cleaner PDC-32G (Harrick Plasma, Ithaca, NY, USA), placed in 24well plates and then seeded with 5x103 cells/well. MC3T3-E1 cells were cultured in
serum containing medium, as described elsewhere.25 After 6 and 24 h incubation at 37 °C
in a humidified atmosphere of 5%CO2 in air, the cells were washed, fixed with 4%
paraformaldehyde (PFA) in PBS, permeabilized with 0.1% Triton-X 100 in PBS for
5 min and then blocked using 3% bovine albumin (BSA) for 30 min. For visualization of
vinculin and filamentous actin (F-actin), substrata were incubated with primary antibody
against vinculin (1:100 in 3% BSA in PBS; Millipore, Billerica, MA, USA) for 1 h,
rinsed three times with PBS and then incubated for 1.5 h with Alexa Fluor 488conjugated goat anti-mouse IgG secondary antibody (1:200 dilution in 3% BSA in PBS;
Life Technologies, Burlington, CA) and rhodamine-conjugated phalloidin (1:100 dilution
in 3% BSA in PBS; Cytoskeleton Inc., Denver, CO, USA). To counterstain nuclei,
Vectashield (Vector Laboratories, Burlingame CA) with 4', 6-diamidino-2-phenylindole
dihydrochloride (DAPI) was used.
An Axio Observer Z.1 fluorescence microscope (Carl Zeiss, Jena, Germany) and
AxioImager software was used to assess cell attachment, actin distribution and focal
adhesion formation by capturing images from 10 randomly selected fields from each
specimen. Cell attachment was analyzed by counting nuclei. The total number of focal
adhesion per cell was measured by an impartial observer using ImageJ software (National
Institutes of Health, USA). The average number of focal adhesions (based on vinculin
labeling) was determined for 10 randomly selected cells on each sample. Three
independent experiments were performed, each with triplicate specimens.
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4.2.3.2 Cell Proliferation Assay
CyQuant® cell proliferation assay kit (Invitrogen, Burlington, CA) was used to assess the
number of MC3T3-E1 osteoblastic cells on WGC and YZ discs at 1, 3, 5 and 7 days,
according to the manufacturer’s protocol.

4.2.3.3 Quantification of Alkaline Phosphatase Activity
Osteoblast differentiation was evaluated by monitoring alkaline phosphatase (ALP)
activity. Rat calvarial osteoblasts (passage 2-3) were used for these experiments. Cells
were generously provided by Dr. D.W. Hamilton (Schulich Dentistry, Western
University). Cells were isolated from 0-5-day old neonatal Sprague Dawley rats
according to a previously published protocol.26 Animal procedures were approved by the
University Council on Animal Care of Western University and were in agreement with
the Canadian Council on Animal Care.
ALP was determined by measuring the cleavage of p-nitrophenyl phosphate (SensoLyte®
pNPP colorimetric assay; ANASPEC, Fremont, CA, USA). Osteoblasts were incubated
on WGC and YZ discs and cultured for 3 days in standard culture medium.25 Afterwards,
the medium was replaced by differentiation medium that consisted of standard culture
medium supplemented with 50 µg/mL ascorbic acid and 2 mM β-glycerophosphate. Cells
were incubated for an additional 1, 4 and 7 days, refreshing the medium every 2-3 days.
At the scheduled times, the cell monolayer was washed and then lysed with lysis buffer
containing 0.2% Triton X-100. The resulting suspension was sedimented at 2500 g for
10 min at 4°C, and the supernatant was collected and stored at -80 °C. Subsequently,
50 µL of each sample was mixed with 50 µL of pNPP solution on 96-well clear micro-
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plate by gently shaking the plate for 30 sec, and incubated at 37 °C for 60 min. Reactions
were terminated by adding 50 µL of 0.05 M NaOH into each well and absorbance was
read at 405 nm on a micro-plate reader (Tecan Safire, Morrisville, NC, USA). ALP
activity was calculated according to a series of alkaline phosphatase standards. The
protein concentration for each sample was calculated using BCATM protein assay kit
(Thermo Scientific Pierce Biotechnology, Waltham, MA, USA), according to the
manufacturer’s instructions. ALP activity was normalized to total protein concentration
and expressed as µg pNP/h/µg total protein.

4.2.4 Statistical Analyses
Differences between two groups were evaluated by Student’s t-tests. One-way analysis of
variance (ANOVA) followed by Tukey’s multiple comparisons test was used to evaluate
differences among three or more groups. All statistical analyses were accepted as
significant at p<0.05. Data are expressed as means (SD) of three independent experiments
(n=3), each with triplicate samples.

4.3 RESULTS
4.3.1 Bioactivity:
4.3.1.1 Scanning Electron Microscopy and Energy Dispersive X-Ray
Spectroscopy
WGC and YZ displayed different behaviors when soaked in SBF. SEM revealed the
surface features of WGC and YZ at 0 weeks before soaking in SBF (Figure 4-1). After 1
week soaking in SBF, WGC surface morphology changed with the precipitation of a
partial thin coating. As the soaking time was increased, the formation of a uniform
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surface layer with morphology similar to that of biomimetic HA27,28 was observed. The
entire surface of the WGC was fully covered by that layer following 4 weeks of soaking.
In contrast, no precipitate was observed on the YZ surfaces even after up to 4 weeks of
soaking in SBF, indicating lack of bioactivity.
EDX elemental analysis spectra are shown in Figure 4-2. In the case of WGC, Ca and P
peaks increased in intensity with the gradual reduction of the Si peak after soaking in SBF
at the different time points. EDX analysis confirmed that the precipitate was Ca-P rich
and that, at 4 weeks soaking time, Si was no longer detectable. To the contrary, there was
no change in the EDX spectra of YZ for all the time points up to 4 weeks. The zirconium
was the principal peak before and after soaking in SBF. Importantly, no phosphorus or
calcium was detected, in spite of soaking in SBF up to 4 weeks, consistent with the SEM
data.

4.3.1.2 X-Ray Diffraction
XRD patterns of WGC and YZ, before and after soaking in SBF, are shown in Figure 4-3.
It can be observed that the XRD peaks associated with the starting material gradually
diminished as soaking time was increased. After 4 weeks, only peaks attributable to
carbonated HA were observed. The main peaks had 2θ values equal to 26°and 32°
(Figure 4-3A), confirming the formation of an apatite layer.29 In keeping with the SEM
and EDX data, XRD did not reveal any carbonated HA on YZ surfaces at any time points
(Figure 4-3B). Taken together, these findings establish that WGC supports the formation
of a uniform, thick apatite layer in contrast to YZ, which is not bioactive.
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Figure 4-1: SEM images of wollastonite glass-ceramic (WGC) and In-Ceram yttria
partially stabilized zirconia (YZ) before (0 week) and after (1, 2 and 4 weeks) soaking in
simulated body fluid (SBF). SEM micrographs show the surface features of WGC and YZ
before soaking in SBF (0 week), and the evolution of HA layer on the WGC surfaces (1,
2 and 4 weeks). There was no HA formed on YZ surfaces at any time. Scale bar = 3 µm
in all panels.
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Figure 4-2: EDX spectra illustrating the elemental analysis of WGC and YZ surfaces
after 0, 1, 2 and 4 weeks soaking in SBF. EDX spectra of WGC display the peaks of the
main elements (Si, Ca, P) before and after soaking in SBF. YZ spectra indicate the lack
of bioactivity by showing the same peak (Zr) at different time points. Spectra are
representative of three different locations on the specimens’ surfaces.
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Figure 4-3: XRD pattern of WGC and YZ specimens before and after soaking in SBF.
(A) XRD spectra of WGC confirmed the gradual formation of poorly crystalline HA
surface layer. After 4 weeks, WGC is totally covered with HA layer, where XRD showed
the spectrum of carbonated HA only (PDF # 19-272). The black circles above the spectra
indicate the main peaks at 26° and 32°. (B) There were no changes in the XRD spectra
of the YZ at the different time points.
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4.3.2 Biocompatibility
4.3.2.1 Osteoblast Attachment and Morphology
To compare cell attachment and morphology on WGC and YZ surfaces, MC3T3-E1
osteoblast-like cells were cultured for 6 and 24 h. Fluorescence images indicated that cells
attached and spread well on both substrata (Figure 4-4). After 6 h, cells had circular
peripheries and there were no obvious stress fibers on either material (Figure 4-4B, D).
However, after 24 h, the cells exhibited flattened polygonal morphology with multiple
cytoplasmic extensions and highly organized actin stress fibers, consistent with extensive
actin polymerization and adhesion to the substrata (Figure 4-4F,H).
Regarding cell attachment, there was no significant difference between the number of
osteoblastic cells on WGC and YZ at either time point (p>0.05, Figure 4-5A). Focal
adhesions were detected by immunofluorescence imaging of vinculin-labeled cells after 6
and 24 h of cell incubation (Figure 4-4). The focal adhesion counts on 10 randomly
selected cells are displayed in Figure 4-5B. The number of the focal adhesion increased
significantly from 6 to 24 h on WGC (p<0.05); however, there were no significant
differences in the number of focal adhesions on WGC and YZ at either time.

4.3.2.2 Cell Proliferation Assay
The ability of WGC and YZ to support osteoblast proliferation was investigated using the
CyQuant© cell proliferation assay. Cells were cultured for 1-7 days on both surfaces and
the number of cells on each material was plotted (Figure 4-6A). Cells proliferated on
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WGC and YZ and, by day 7, there was significantly higher cells count on both surfaces
(p<0.05).

4.3.2.3 Alkaline Phosphatase activity (ALP)
ALP is a classical marker associated with the early stages of osteoblast differentiation and
it plays a critical role in promoting mineralization of the extracellular matrix.30,31
Calvarial cells were cultured on WGC and YZ discs in medium supplemented with
ascorbic acid and β-glycerophosphate to induce osteoblastic differentiation. ALP activity
was measured and normalized to the amount of protein per sample (Figure 4-6B). On
both substrata, ALP activity increased with time. At day 7, the ALP activity was 2.4 fold
higher than at day 1 for WGC and 1.5 fold for YZ. However, there was no significant
difference between the ALP activity of cells on WGC and YZ at any time point (p>0.05).

Figure 4-4:

Representative

fluorescence

images

of

MC3T-E1

cell

attachment,

morphology spreading and focal adhesions on WGC and YZ substrata after 6 and 24 h
of incubation. Images were captured at low (A, C, E and G) and high (B, D, F and H)
magnifications. The nuclei were stained with DAPI (blue), F-actin with rhodamine
phalloidin (red) and focal adhesions with vinculin (green).
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Figure 4-5: MC3T3-E1 cell count (A) and focal adhesion count (B) on WGC and YZ
specimens after 6 and 24 h of incubation. There was no significant difference between
cell count on both materials after 6 or 24 h incubation. On the other hand, focal adhesion
count increased significantly on WGC after 24 h of incubation. The data are means (SD)
of 9 samples from 3 independent experiments (n=3). *Indicates significant effect of time,
analyzed by Student’s t-test (p<0.05).
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Figure 4-6: (A) MC3T3-E1 cell proliferation on WGC and YZ. CyQuant® fluorescence
proliferation assay was used to quantify cell number up to 7 days. Data are means (SD),
n=3. * Indicates that cell number at day 7 was significantly higher than that at day 1, 3,
and 5 for both materials (p<0.05) based on ANOVA and Tukey’s multiple comparisons
test. (B) Calvarial osteoblasts were cultured on WGC and YZ specimens for 1, 4 and
7 days. Alkaline phosphatase activity was measured and normalized to total protein.
Data are means (SD), n=3. There was no significant difference in ALP activity between
materials at any time point (ANOVA and Tukey’s multiple comparisons test, p>0.05).
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4.4 DISCUSSION
Formation of bone-like apatite is an essential requirement for the bioactivity of materials.
The first step for predicting in vivo bioactivity of a new material is soaking the material in
SBF and evaluating the formation of apatite layer on its surface.22 In the present study,
SEM, EDX and XRD analyses revealed the bioactivity of WGC and confirmed that YZ is
not bioactive. A bioactive material creates an interface with the surrounding bone and
promotes a long functional life of the dental implant.32
Bioactivity mechanisms have been discussed thoroughly in the literature.33-35 It starts with
apatite nuclei formation on the surface of the biomaterial that later grow over the entire
surface by consuming calcium and phosphate ions from the SBF. Carbonate anions are
later incorporated within the formed apatite, leading to formation of carbonated HA.22,33,35
In the present study, the WGC starting material showed various peaks attributed to the
crystalline phases of WGC. In spite of the presence of apatite as a secondary crystalline
phase in WGC (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1), its
bioactivity was ascribed to an apatite layer that formed on its surface after soaking in
SBF. After soaking in SBF for increasing times, WGC peaks decreased in intensity until
they totally disappeared at 4 weeks and were replaced with broad diffraction peaks of
carbonated HA. These new broadened peaks indicate formation of a poorly crystalline
structure, similar to bone apatite.36 Kokubo34 developed an apatite-wollastonite GC in an
MgO-CaO-SiO2-P2O2 glass system. This GC showed bioactivity with satisfactory
mechanical properties. Kokubo established that, with bioactive materials, osteoblasts
proliferate on formed apatite surfaces in preference to other cells. Consequently, the
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surrounding bone comes into direct contact with the GC without intervention of fibrous
tissue, establishing a strong chemical bond between the formed apatite and the bone
apatite.34,37 Another study confirmed that bioactive GC could initiate biomineralization in
osteoblast cultures, leading to a direct bond between the formed apatite layer on the
bioactive GC and the mineralized extracellular matrix.38 All these studies revealed the
excellent osteoconductivity of HA layer.
Cell cultures provide an important tool to determine in vitro biocompatibility of
biomaterials. Moreover, osteoblast attachment on the implant surface is a key factor for
successful osseointegration to occur. We focused on the initial cell-implant interactions
including attachment, focal adhesion formation, proliferation and ALP activity. We
compared the behavior of WGC to that of a positive control YZ, which exhibits excellent
biocompatibility, comparable to commercially used titanium dental implants.1,4,7,18,20,39,40
In the present study, cells exhibited favorable morphological features on WGC and YZ,
indicating that WGC is comparable in its biocompatibility to YZ.
The formation of focal adhesions is considered to be one of the early steps essential for
subsequent cell migration, proliferation and differentiation before formation of bone
tissue.19 On both WGC and YZ, osteoblasts exhibited focal adhesions indicating that
extracellular matrix proteins, membrane proteins and cytoskeletal proteins interacted
together effectively.41 After 24 h, the focal adhesion number on WGC surfaces increased
significantly compared to the number after 6 h, consistent with a positive enduring
interaction between the cells and the substratum.42
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Both WGC and YZ supported cell proliferation. Various osteoblastic cells have been used
previously to study proliferation kinetics on zirconia and apatite wollastonite composite
glass ceramic materials. MC3T3-E1 and CAL-72 cell lines proliferated significantly on
zirconia surfaces.18,41 Similarly, human osteoblasts proliferated and formed dense cell
layers on zirconia surfaces.19,39 Also, apatite-wollastonite composite glass ceramic
supported the proliferation of Saos-2 osteoblast-like cells.39
Osteogenesis through osteoblast differentiation and extracellular matrix formation is
required for subsequent implant osseointegration. In the current study, primary calvaria
cells were used to evaluate ALP activity levels on WGC and YZ substrata. Primary cells
were selected instead of the MC3T3-E1 cell line because most cell lines do not
demonstrate a complete pattern of in vitro differentiation.21 ALP activity was maintained
in osteoblasts on both materials at comparable levels. Similarly, previous studies have
shown that zirconia surfaces, regardless of their roughness or topography, supported ALP
expression by osteoblastic cells.18,43,44
Overall, WGC and YZ had comparable interactions with cells. This can be attributed to
two reasons. First, topography of material plays a critical role in cell-implant
interaction26,41,45 and both WGC and YZ had relatively smooth surfaces due to the
sintering process. Second, both of these materials are chemically durable; YZ was proved
to be bioinert3 and WGC was found to be chemically durable (Saadaldin et al, accepted
for publication, DEMA-D-13-00398R1). The possible toxicity of WGC and YZ is
believed to be negligible because of their excellent chemical durability and insignificant
degradation and dissolution rates. Further in vitro and in vivo studies will be required to
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understand the effects of WGC on gene expression and to elucidate the interaction
between oral tissues and the WGC implant material.

4.5 CONCLUSIONS
We established that WGC is bioactive and forms a complete apatite layer on its surface
within 4 weeks in SBF. In vitro biocompatibility tests showed that WGC supported
osteoblast attachment, focal adhesion formation, cell proliferation and ALP activity. The
biocompatibility of WGC was comparable to that of the positive control, In-Ceram yttria
partially stabilized zirconia. We have previously shown that WGC has chemical and
mechanical properties – including machinability – suitable for the fabrication of onepiece dental implants (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1),
The results of the present study establish that WGC is bioactive and biocompatible and,
thus, a promising material for non-metallic dental implants applications.
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CHAPTER 5
GENERAL DISCUSSION
This chapter provides an overall summary of the important findings, their significance
and general conclusions of the work. The limitations and future directions are presented.

Despite substantial gains in the discovery of new materials for dental applications in
recent years1 there is an ongoing search for dental implant materials to satisfy combined
properties such as superior mechanical properties, biocompatibility, bioactivity,
machinability, handling properties and cost. The main goal of this work was to develop
GCs with suitable mechanical and biological properties for non-metallic one-piece dental
implant applications. An implant can be the treatment of choice when natural teeth are
lost and the masticatory function is diminished. Prevalence of partial and complete tooth
loss is increasing among the population of different ages2 due to many reasons:
1.

Epidemic of dental caries and periodontal disease in modern societies.3

2.

Traumatic dental injuries, as a result of various contributing factors (malocclusion,
teeth grinding and clenching), physical trauma (motor vehicle accidents, fighting
and sports injuries), in addition to inappropriate usage of teeth and oral piercing.4

3.

Increased life expectancy and associated increase in older population, especially.5

4.

Congenital missing teeth and other diseases, such as cancer.6
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Patients have high expectations regarding the esthetics and biocompatibility of their
dental restorations. Advanced ceramic materials such as zirconia and glass-ceramics (GC)
have great potential as substitutes for metallic biomaterials. (GCs) have been used to
fabricate different restorations including veneers, inlays, onlays, crowns and bridges.
GCs have become one of main interests for dental researchers to improve their esthetic
outcomes and mechanical properties. GCs properties are determined largely by the
number of the crystals formed from the base glass, their growth rate and size. To ensure
superior mechanical performance the GCs, crystals should be numerous and uniformly
distributed throughout the remaining glassy phase.7
To the best of our knowledge, we were the first group that synthesized precursor glasses
by combining wet chemistry and spray drying (Chapters 2 and 3) to synthesize miserite
and wollastonite GCs. Silicon alkoxides were hydrolyzed in an aqueous solution of
metallic salts, the resulting sol was spray dried to produce multicomponent powder
followed by calcination, melting, and quenching to obtain transparent glass frits. Spray
drying is a well-established technique and a widely used industrial process that uses the
aerosol phase to produce homogenous,8 highly reactive, and easily sintered glass powder.9
Sol-gel chemistry improved synthetic methods of the glasses by lowering the melting
temperatures leading to better material properties.10
Pinckney et al11 synthesized precursor glasses (to produce miserite GCs) using a
conventional method: mixing batch components, ball-milling and then melting the
powder at 1475-1500 °C. This method leads to fluorine loss from the melt; the amount of
loss is varied and is associated with the difference in melting conditions.12 It was
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disclosed that the fluorine content in precursor glasses plays a significant role in
improving the sintering and mechanical properties of GCs.13,14 In the current study, the
sol-gel chemistry process lead to a lower melting temperature (1250 °C) of the glasses
(Chapter 2) and kept the intended fluorine content. Differential thermal analysis (DTA)
data was used to determine the ceramming temperature to produce the GCs. Different
heat treatment schedules were used to study its effect on the microstructure and
crystalline phases of the resultant GCs.
X-ray diffraction (XRD) of the GCs showed multi crystalline phases, including calcium
fluoride silicate, xonotolite, hydroxyapatite and miserite. The GC that was produced by
subjecting the glass to heat treatment up to 1000 °C exhibited miserite as the main
crystalline phase and it was identified as GC4 in the study. GC4 exhibited a
microstructure of tightly interlocking crystals that contributed to its toughness and
strength and it is similar to that of miserite GC synthesized in a previous study.11 In spite
of having the same microstructure and the same main crystalline phase (miserite), their
fracture toughness (KIC) values were dissimilar. The KIC of GC4 (4.77±0.27 MPa·m0.5) is
notably higher compared to the KIC values reported by Pinckney et al11 (>3.5 MPa·m0.5).
The dissimilarity of their KIC can be attributed to the synthesis process of the parent glass
that affected the mechanical properties of the resultant GCs.
Young’s modulus (E) is an important mechanical property of implant materials that
affects its osseointegration and compatibility with adjacent bone.15 In addition, E also
contributes to the preservation of the vitality of the surrounding bone16 through effective
transfer of forces to adjacent bone. The E values of the current dental implants such as
titanium (100-116 GPa)17 and zirconia (200-210 GPa)18 were drastically higher than that

146

of human bone, which can range from 0.61 GPa to17 GPa.17,19,20 GC4 has an E value of
96±2.54 GPa, that is notably lower than that of titanium or zirconia, yet a long way from
an ideal match to that of the human bone.
GC4 specimens (Chapter 2) exhibited excellent machinability; they were milled and
machined using conventional drilling tools, indicating the possibility of introducing GC4
to CAD-CAM systems. The random interlocking microstructure of different GC crystals
acts as a barrier against catastrophic crack propagation.21 The degree of the interlocking
of the GC crystals will determine the ease of its machinability.22 Studies showed that
some machinable materials could suffer from chipping defects, surface flaws, and
microcracks, which reduce their mechanical strength and lifetime.23 GC4 was milled and
drilled to prepare different shapes such as marginal finish lines (shoulder, chamfer),
grooves, holes and bevels without chipping or developing microcracks. The excellent
machinability of GC4 was assessed quantitatively by calculating the brittleness index
(BI). Boccaccini 24 proposed BI as a parameter for evaluating the machinability of brittle
materials like glass and GCs, by combining both KIC and the hardness values to evaluate
the deformation and micro fracture phenomena responses of the materials.. GC4 had a BI
value of 1.11±0.05 µm-0.5 indicating excellent machinability.
Current dental implant materials, titanium and zirconia, have particular properties for
direct functionability as implant materials, but they lack important features like
osteogenic and osteoconductive capacity25 or bioactivity.26 Even though different
mechanical and chemical modifications were applied to improve these qualities, and to
prevent inflammatory reactions that could lead to fibrous encapsulation of the implant,
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osteoconductive and bioactivity are still considered critical issues in any implant
treatment.25
GC4 specimens exhibited bioactivity; a successful deposition of continuous and compact
HA layer was detected using XRD, EDX and SEM, after soaking in SBF for 4 weeks.
The microstructure and chemical composition of the HA layer was similar to the mineral
phase in bone; this result was in agreement with the outcome of bioactivity testing of
other biomaterials.27-30 Formation of HA on the implant surfaces leads to direct bonding
to living tissues without the formation of fibrous tissue that hinders the
osseointegration.29,31 Alemany et al 29 disclosed the effect of the GC synthesis method
and the microstructure on bioactivity; GC that was obtained by ceramming a glass that
prepared by the sol-gel method formed HA layer sooner than that synthesized by the
conventional method, although both of them exhibited bioactivity.
Implant biomaterials have to be biocompatible to surrounding cells and tissues, to prevent
inflammation and osteolysis that occur as a result of toxic or corrosion products, and to
promote osseointegration and mechanical stability.26 It was shown in the current study
that osteoblast-like cells attached, spread and proliferated on GC4 in a comparable level
to biocompatible titanium materials,32-34 indicating its biocompatibility and the absence of
toxic effects on cells. In spite of the favorable mechanical and biological properties of
GC4, preliminary results of chemical stability were less promising (Appendix B). As a
result, we were motivated to modify the composition of the GC to improve the chemical
durability and to preserve its mechanical and biological properties.
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In Chapter 3 (Synthesis and characterization of wollastonite glass-ceramics for dental
implant applications), three precursor glasses were synthesized following the same
procedure executed in Chapter 2. Glass melting experiments were performed to prepare
the glasses with the lowest melting temperature to prevent the loss of fluorine and to
avoid uncontrolled crystallization. DTA was used to determine the crystallization kinetics
of the GCs.
XRD of the GC specimens revealed that wollastonite was the main crystalline phase of all
GCs accompanied with other secondary phases (hydroxyapatite and fluorite). One GC
had cristobalite as an additional phase and was identified as WGC. Scanning electron
microscopy (SEM) of the GCs showed dense acicular interlocking crystals. The KIC of
WGC was significantly higher (p<0.05) than other GCs (4.91±0.26 MPa·m0.5). All GCs
exhibited excellent machinability. Young’s modulus of WGC was 90±2.98 GPa. In
summary, WGC had favorable properties with a lower E value and a higher KIC than GC4
previously synthesized in Chapter 2.
One of the objectives in Chapter 3 was to test the chemical stability of WGC. The results
were very encouraging; the WGC weight loss/unit area in 4% acetic acid satisfied ISO
6872 35 specification for dental ceramics, indicating its superb chemical durability. The
chemical stability was similar to the chemically durable YZ that is used widely to
construct dental restorations.36 Degradation testing (ISO 10993-14)37 of the WGC showed
insignificant degradation ranging from 0% at day 1 to 0.36% after 120 days of soaking in
tris buffered solution. Assessment of the KIC of WGC after the chemical stability tests
showed no significant effect on the KIC values (p>0.05), providing support that soaking
GC specimens in different solutions for various time periods did not affect mechanical
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properties. In general, we concluded that WGC had both superior chemical stability and
mechanical properties among the GCs in the study. As a result, it was selected for
investigation of bioactivity and biocompatibility presented in Chapter 4.
In chapter 4 (Bioactivity and Biocompatibility of a Novel Wollastonite Glass-Ceramic),
bioactivity testing of WGC was performed by soaking specimens in SBF for different
time. SEM, XRD and EDX revealed that WGC promoted the formation of bone-like HA
on the surfaces of the specimens. These results were in agreement with other in vitro and
in vivo studies of bioactivity of wollastonite GC.28,30,38-41 The synthesis procedures,
chemical compositions, and mechanical properties of these GCs were different from the
WGC that was synthesized in Chapter 3, but all of these GCs including WGC had
wollastonite as the main crystalline phase. These studies showed that both wollastonite
and pseudowollastonite GCs were bioactive. It was observed that the formation of apatite
on wollastonite ceramics was faster than that on other bioglass or GCs in SBF.30
Bioactivity of dental implants plays a critical role in improving its osseointegration,42 in
which osteoblast proliferate on the formed apatite layer leading to direct contact between
implant material and surrounding bone, thus establishing a strong chemical bond between
the newly formed apatite and bone.28,43
The biocompatibility of WGC was assessed in Chapter 4 in comparison with the
biocompatible zirconia (YZ).44-46 All tests compared forwardly to YZ, indicating the
excellent biocompatibility of WGC and absence of any possible toxic reactions. Attached
cells showed favorable morphological features of flattened polygonal morphology with
multiple cytoplasmic extensions accompanied with highly organized actin stress fibers.
Focal adhesion (FA) formations on WGC increased significantly with increased culture
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time of the osteoblast cells, indicating a positive reaction of cells. FA is directly related
to cell spreading under all conditions.47 FA formation is also the indication of subsequent
cell migration, proliferation, and differentiation that precedes new bone formation.48
Lastly, WGC supported osteoblast proliferation; a result in agreement with other studies
of osteoblast proliferation on apatite-wollastonite GC.44,49
Alkaline phosphatase (ALP) is a widely recognized biochemical marker used to evaluate
osteoblast differentiation, which is required for osteogenesis and subsequent implant
osseointegration.50 ALP activity was retained and increased with time on WGC
specimens, indicating the ability of the osteoblast to differentiate – leading to in vivo
initiation of bone calcification and consequent HA crystal formation.51 Overall, WGC
showed positive interactions with osteoblasts by supporting their attachment,
proliferation, and keeping up FA formation and ALP activity.
To the best of our knowledge, WGC is a novel material proposed for non-metallic, onepiece dental implant applications owing to its appropriate mechanical and chemical
properties, machinability, bioactivity and biocompatibility. WGC is a promising
biomaterial to satisfy the public as well as the dental profession new trend towards metalfree restorations.
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5.1 LIMITATION OF THE RESEARCH AND FUTURE DIRECTIONS
5.1.1 Limitations
There are limitations encountered in the work done in the thesis:
1. In spite of superior mechanical properties, excellent bioactivity and biocompatibility,
miserite GC exhibited inadequate chemical stability. Modifications of the chemical
composition and/or heat treatment schedules are required to preserve the miserite as
the main crystalline phase and to improve its chemical stability – either in accordance
to ISO 6872 of dental ceramics and in accordance to ISO 10993-14.
2. Chemical durability of the GCs was evaluated based on ISO 6872 (on acidic
environment) and on ISO 10933-14 (in neutral pH). Yet, recent study disclosed that
basic pH buffer solution (pH of 10) resulted in a complete breakdown of the silica
network of the dental ceramics.52
3. Fatigue resistance is an essential property of dental implants. In vitro study disclosed
that one-piece zirconia and titanium dental implant specimens failed after subjected to
stepped fatigue-loading test.53 The tests showed that the fatigue strength of zirconia
was three times lower than that of titanium dental implants. Although Young’s
modulus, true hardness, and fracture toughness of WGC were considered suitable for
dental implant applications, another critical property of dental implant such as fatigue
resistance was not tested.
4. Mature osteoblasts influence osteoclastogenesis and normal bone remodeling.54
Hence, further investigation in osteoblast marker gene expressions, mineral deposits
in the osteoblast cultures and osteoclast activity on WGC specimens will be required.
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5. The incidences of marginal infection, peri-implant mucositis, and peri-implantitis are
increasing significantly. These incidences are considered being one of the
fundamental factors of implant failure.55 Therefore, evaluating the biocompatibility of
implant materials with gingival fibroblast, bacterial adhesive properties on their
surfaces, and their anti-inflammatory properties are the fundamental tests for dental
implants.56

5.1.2 Future Directions
This thesis provides the groundwork on the synthesis process, characterization, and
potential application of a strong, chemically durable, machinable, bioactive, and
biocompatible wollastonite GC for non-metallic one-piece dental implants. The following
experiments are suggested to investigate further areas to set the stage for clinical
applications:
1.

Testing the dynamic fatigue strength of WGC using ISO 14801 standard to
determine the functional loads of WGC under two different environments – dry and
simulated body conditions.

2.

Retesting the dynamic fatigue strength of WGC after the assessment of its chemical
durability in 4% acetic acid for 16 h at 80 °C, and chemical degradation in TBS for
120 days at 37°C.

3.

Assessment of other bone markers, including osteoblast gene expression markers
and osteoclast cell activity.
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4.

Conducting in vivo studies in animal models such as dogs or monkeys to investigate
WGC behavior when implanted in living bone and to ascertain its bioactivity and
biocompatibility.

5.

Testing the chemical stability of WGC in basic buffered solutions (pH of 10).
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APPENDIX B
Preliminary results of the Chemical stability of miserite GC (Chapter 2)
Chemical Durability of miserite GC
Chemical durability of the miserite GC (GC4) was evaluated by measuring mass loss/
unit area after soaking the samples in 4% AC, pH=2, according to ISO standard 6782 for
dental ceramics. Mass loss was significantly lower than the ISO specification (less than
100 µg/cm2), which means that GC4 cannot be exposed to the harsh oral cavity
environments.

Properties
Mass loss/Unit
area (µg/cm2)

GC4
8332(490)
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Chemical Degradation of miserite GC
Chemical Degradation of GC4 Degradation test of the experimental miserite GC showing
weight loss percentage of the GC specimens after soaking in tris buffered solution (TBS)
from 1 day up to 120 days. Weight loss percentage of the specimens was 3% after 120
days soaking in TBS Exponential growth equation was used to show nonlinear fit curve
for the degradation rates at different timeline.
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